UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM N-CSR

CERTIFIED SHAREHOLDER REPORT OF REGISTERED

MANAGEMENT INVESTMENT COMPANIES


Investment Company Act file number   811-02546


Fidelity Commonwealth Trust

 (Exact name of registrant as specified in charter)


245 Summer St., Boston, Massachusetts 02210

 (Address of principal executive offices)       (Zip code)


Cynthia Lo Bessette, Secretary

245 Summer St.

Boston, Massachusetts  02210

(Name and address of agent for service)



Registrant's telephone number, including area code:

617-563-7000



Date of fiscal year end:

November 30



Date of reporting period:

November 30, 2019





Item 1.

Reports to Stockholders



Fidelity® Nasdaq Composite Index® Tracking Stock



Annual Report

November 30, 2019

FIDELITY INVESTMENTS
See the inside front cover for important information about access to your fund’s shareholder reports.


FIDELITY INVESTMENTS

Beginning on January 1, 2021, as permitted by regulations adopted by the Securities and Exchange Commission, paper copies of a fund’s shareholder reports will no longer be sent by mail, unless you specifically request paper copies of the reports from the fund or from your financial intermediary, such as a financial advisor, broker-dealer or bank. Instead, the reports will be made available on a website, and you will be notified by mail each time a report is posted and provided with a website link to access the report.

If you already elected to receive shareholder reports electronically, you will not be affected by this change and you need not take any action. You may elect to receive shareholder reports and other communications from a fund electronically, by contacting your financial intermediary. For Fidelity customers, visit Fidelity's web site or call Fidelity using the contact information listed below.

You may elect to receive all future reports in paper free of charge. If you wish to continue receiving paper copies of your shareholder reports, you may contact your financial intermediary or, if you are a Fidelity customer, visit Fidelity’s website, or call Fidelity at the applicable toll-free number listed below. Your election to receive reports in paper will apply to all funds held with the fund complex/your financial intermediary.

Account Type  Website  Phone Number 
Brokerage, Mutual Fund, or Annuity Contracts:  fidelity.com/mailpreferences  1-800-343-3548 
Employer Provided Retirement Accounts:  netbenefits.fidelity.com/preferences (choose 'no' under Required Disclosures to continue to print)  1-800-343-0860 
Advisor Sold Accounts Serviced Through Your Financial Intermediary:  Contact Your Financial Intermediary  Your Financial Intermediary's phone number 
Advisor Sold Accounts Serviced by Fidelity:  institutional.fidelity.com  1-877-208-0098 


Contents

Performance

Management's Discussion of Fund Performance

Premium/Discount Analysis (Unaudited)

Investment Summary

Schedule of Investments

Financial Statements

Notes to Financial Statements

Report of Independent Registered Public Accounting Firm

Trustees and Officers

Shareholder Expense Example

Distributions

Board Approval of Investment Advisory Contracts and Management Fees


To view a fund's proxy voting guidelines and proxy voting record for the 12-month period ended June 30, visit http://www.fidelity.com/proxyvotingresults or visit the Securities and Exchange Commission's (SEC) web site at http://www.sec.gov.

You may also call 1-800-FIDELITY to request a free copy of the proxy voting guidelines.

Nasdaq®, OMX®, NASDAQ OMX®, Nasdaq Composite®, and The Nasdaq Stock Market®, Inc. are registered trademarks of The NASDAQ OMXGroup, Inc. (which with its Affiliates are the Corporations) and are licensed for use by Fidelity. The product has not been passed on by the Corporations as to its legality or suitability. The product is not issued, endorsed or sold by the Corporations. The Corporations make no warranties and bear no liability with respect to shares of the product.

Standard & Poor's, S&P and S&P 500 are registered service marks of The McGraw-Hill Companies, Inc. and have been licensed for use by Fidelity Distributors Corporation.

Other third-party marks appearing herein are the property of their respective owners.

All other marks appearing herein are registered or unregistered trademarks or service marks of FMR LLC or an affiliated company. © 2020 FMR LLC. All rights reserved.



This report and the financial statements contained herein are submitted for the general information of the shareholders of the Fund. This report is not authorized for distribution to prospective investors in the Fund unless preceded or accompanied by an effective prospectus.

A fund files its complete schedule of portfolio holdings with the SEC for the first and third quarters of each fiscal year on Form N-PORT. Forms N-PORT are available on the SEC’s web site at http://www.sec.gov. A fund's Forms N-PORT may be reviewed and copied at the SEC’s Public Reference Room in Washington, DC. Information regarding the operation of the SEC's Public Reference Room may be obtained by calling 1-800-SEC-0330.

For a complete list of a fund's portfolio holdings, view the most recent holdings listing, semiannual report, or annual report on Fidelity's web site at http://www.fidelity.com, http://www.institutional.fidelity.com, or http://www.401k.com, as applicable.

NOT FDIC INSURED •MAY LOSE VALUE •NO BANK GUARANTEE

Neither the Fund nor Fidelity Distributors Corporation is a bank.



Performance: The Bottom Line

The fund's net asset value (NAV) performance is based on the NAV calculated each business day. It is calculated in accordance with the standard formula for valuing mutual fund shares as of the close of regular trading hours on The Nasdaq Stock Market, normally 4:00 p.m. Eastern time (or NYSE if NASDAQ is closed). The fund's market price performance is based on the daily closing price of the shares of the fund on The Nasdaq Stock Market.

Cumulative total returns reflect performance over the period shown generally by adding one year's return — positive or negative — to the next year's return. NAV and closing market price average annual returns reflect the change in the value of an investment, assuming reinvestment of distributions from dividend income and capital gains (the profits earned upon the sale of securities that have grown in value, if any), at NAV and Market Price, respectively, and assumes a constant rate of performance each year. The hypothetical investment and the fund's returns do not reflect the deduction of taxes that a shareholder would pay on fund distributions or the redemption or selling of fund shares. How a fund did yesterday is no guarantee of how it will do tomorrow.

Cumulative Total Returns

Periods ended November 30, 2019  Past 1 year  Past 5 years  Past 10 years 
Fidelity® Nasdaq Composite Index® Tracking Stock - NAV  19.83%  90.70%  346.80% 
Fidelity® Nasdaq Composite Index® Tracking Stock - Market Price  19.89%  90.39%  348.43% 
Nasdaq Composite Index®   19.51%  91.36%  352.71% 
S&P 500  16.11%  68.34%  252.89% 

Average Annual Total Returns

For the periods ended November 30, 2019  Past 1 year  Past 5 years  Past 10 years 
Fidelity® Nasdaq Composite Index® Tracking Stock - NAV  19.83%  13.78%  16.15% 
Fidelity® Nasdaq Composite Index® Tracking Stock - Market Price  19.89%  13.74%  16.19% 

$10,000 Over 10 Years

Let's say hypothetically that $10,000 was invested in Fidelity® Nasdaq Composite Index® Tracking Stock - NAV on November 30, 2009.

The chart shows how the value of your investment would have changed, and also shows how the Nasdaq Composite Index® and S&P 500 Index performed over the same period.


Period Ending Values

$44,680 Fidelity® Nasdaq Composite Index® Tracking Stock - NAV

$45,271 Nasdaq Composite Index®

$35,289 S&P 500 Index

Management's Discussion of Fund Performance

Market Recap:  U.S. stocks continued to roll for the year ending November 30, 2019, with the S&P 500® index soaring 16.11% and marking history as the longest and strongest bull market ever, despite persistent, nagging concerns about global growth and trade. After a rough December 2018, upbeat company earnings, along with signs the Fed may pause on rates, boosted stocks to an all-time high on April 30. In May, however, volatility spiked and the index sunk as trade negotiations between the U.S. and China broke down. The bull market roared back to recorded a series of highs in July, when the Fed, affirming a dovish shift in policy, cut interest rates for the first time since 2008. Volatility intensified in August, however, as the Treasury yield curve inverted for the first time since 2007, which some investors viewed as a sign the U.S. economy could be heading for recession. The market proved resilient, however, achieving a new high on October 30, when the Fed lowered rates for the third time this year. The rally continued with a strong November (+4%). Information technology (+32%) led the way, as investors regained comfort taking on risk. Communication services (+21%) also stood out, followed by real estate (+18%) and utilities (+17%). In contrast, energy (-8%) was by far the weakest group – struggling amid sluggish oil prices – while several solid gainers nonetheless fell short of the market: health care (+7%), consumer staples and materials (+13% each), financials and consumer discretionary (+14% each), and industrials (+16%).

Comments from the Geode Capital Management, LLC, passive equity index team:  For the fiscal year, the exchange traded fund's (ETF) net asset value gained 19.83%, compared with an increase of 19.51% for the benchmark NASDAQ Composite Index. The ETF's market price rose 19.89% over the same time frame. At the individual-stock level, the largest positive impact on performance came from the two largest companies in the index, Apple and Microsoft. Apple (+52%), a maker of consumer electronics and personal computers, reported especially strong growth in services and wearable electronics, while software company Microsoft (+39%) benefited from strong earnings growth and a decision to buy back stock and increase its quarterly dividend. Better-than-expected financial results lifted shares of social media company Facebook (+43%). Other notable contributors included Alphabet (combining its Class A and Class C shares), parent company of online search giant Google – whose shares rose on the company's strong financial results and announcement of a $25 billion share buyback plan – and online retailer Amazon.com (+7%). In contrast, weak financial results weighed on shares of pharmacy retail chain Walgreens Boots Alliance (-27%). Kraft Heinz (-37%) detracted, with much of its decline coming in February, after the packaged-foods company reported an exceptionally large charge to its quarterly earnings and simultaneously announced a government inquiry into the firm's accounting practices. China-based Baidu (-37%) struggled, as the company anticipated continued challenges for its core online search-advertising business.

The views expressed above reflect those of the portfolio manager(s) only through the end of the period as stated on the cover of this report and do not necessarily represent the views of Fidelity or any other person in the Fidelity organization. Any such views are subject to change at any time based upon market or other conditions and Fidelity disclaims any responsibility to update such views. These views may not be relied on as investment advice and, because investment decisions for a Fidelity fund are based on numerous factors, may not be relied on as an indication of trading intent on behalf of any Fidelity fund.

Note to Shareholders:  On March 22, 2019, Pat Waddell retired and is no longer a portfolio manager with Geode Capital Management.

Premium/Discount Analysis (Unaudited)

Shares of Fidelity® Nasdaq Composite Index® Tracking Stock (the fund) are listed on The Nasdaq Stock Market® and can be bought and sold on the secondary market at market prices. Although the market price is expected to approximate the fund's NAV, it is possible that the market price and NAV will vary significantly. The closing market price is the daily closing price as reported on The Nasdaq Stock Market.

Premiums or discounts are the differences (expressed as a basis point differential with 1 basis point equaling 1/100 of 1%) between the fund's NAV and closing market price. A premium indicates that the closing market price is trading above the NAV. A discount indicates that the closing market price is trading below the NAV. A discrepancy may exist with respect to the timing of when the NAV is calculated and the determination of the closing market price.

The chart below presents information about the differences between the fund's daily closing market price and the fund's NAV.

Period Ended From December 1, 2014 to November 30, 2019

  Closing Price Below NAV  Closing Price Above or Equal to NAV 
Basis Point Differential  Number of Days  % of Total Days  Number of Days  % of Total Days 
0 - <25  341  27.08%  863  68.55% 
25 - <50  0.64%  45  3.57% 
50 - <75  --  0.08% 
75 - <100  --  -- 
100 or above  --  0.08% 
Total  349  27.72%  910  72.28% 

Investment Summary (Unaudited)

Top Ten Stocks as of November 30, 2019

  % of fund's net assets 
Apple, Inc.  7.3 
Microsoft Corp.  7.0 
Amazon.com, Inc.  5.4 
Facebook, Inc. Class A  3.1 
Alphabet, Inc. Class C  2.7 
Alphabet, Inc. Class A  2.4 
Intel Corp.  1.6 
Cisco Systems, Inc.  1.3 
Comcast Corp. Class A  1.2 
PepsiCo, Inc.  1.2 
  33.2 

Top Market Sectors as of November 30, 2019

  % of fund's net assets 
Information Technology  33.7 
Communication Services  14.4 
Consumer Discretionary  10.8 
Health Care  8.7 
Financials  5.6 
Industrials  3.9 
Consumer Staples  3.7 
Real Estate  1.1 
Utilities  0.8 
Materials  0.3 

Asset Allocation (% of fund's net assets)

As of November 30, 2019 * 
    Stocks and Equity Futures  100.0% 


 * Foreign investments - 4.9%

Schedule of Investments November 30, 2019

Showing Percentage of Net Assets

Common Stocks - 83.2%     
  Shares  Value 
COMMUNICATION SERVICES - 14.4%     
Diversified Telecommunication Services - 0.1%     
ATN International, Inc.  3,980  $223,477 
Cogent Communications Group, Inc.  3,949  247,523 
Consolidated Communications Holdings, Inc. (a)  24,894  90,365 
Frontier Communications Corp. (a)(b)  171,387  115,669 
GCI Liberty, Inc. (b)  16,228  1,152,026 
Iridium Communications, Inc. (b)  20,109  468,540 
    2,297,600 
Entertainment - 1.9%     
Activision Blizzard, Inc.  110,422  6,054,438 
Bilibili, Inc. ADR (b)  9,513  164,385 
Electronic Arts, Inc. (b)  42,465  4,289,390 
Glu Mobile, Inc. (b)  2,692  14,887 
iQIYI, Inc. ADR (a)(b)  62,117  1,189,541 
LiveXLive Media, Inc. (a)(b)  5,524  10,606 
NetEase, Inc. ADR  10,934  3,447,709 
Netflix, Inc. (b)  65,773  20,696,132 
Roku, Inc. Class A (b)  13,098  2,100,526 
Take-Two Interactive Software, Inc. (b)  16,239  1,970,603 
Viacom, Inc. Class B (non-vtg.)  53,327  1,283,581 
Zynga, Inc. (b)  143,540  894,254 
    42,116,052 
Interactive Media & Services - 8.9%     
Alphabet, Inc.:     
Class A (b)  39,644  51,699,344 
Class C (b)  45,588  59,490,516 
Baidu.com, Inc. sponsored ADR (b)  47,446  5,623,774 
CarGurus, Inc. Class A (a)(b)  17,582  704,862 
Facebook, Inc. Class A (b)  332,869  67,119,705 
IAC/InterActiveCorp (b)  13,870  3,088,849 
Luokung Technology Corp. (a)(b)  32,954  44,488 
Match Group, Inc. (a)  14,656  1,032,955 
Momo, Inc. ADR  25,047  937,509 
Qutoutiao, Inc. ADR (a)(b)  44,295  129,784 
So-Young International, Inc. ADR (a)  8,897  109,611 
Sohu.Com Ltd. ADR (b)  7,502  76,820 
TripAdvisor, Inc.  25,730  730,732 
Trivago NV ADR (b)  6,451  15,031 
TrueCar, Inc. (b)  32,340  169,785 
Weibo Corp. sponsored ADR (a)(b)  14,867  636,456 
Yandex NV Series A (b)  50,221  2,107,775 
YY, Inc. ADR (b)  8,245  525,949 
Zillow Group, Inc.:     
Class A (a)(b)  8,420  328,885 
Class C (a)(b)  20,629  807,625 
    195,380,455 
Media - 3.0%     
Charter Communications, Inc. Class A (b)  31,052  14,594,751 
Comcast Corp. Class A  610,604  26,958,167 
comScore, Inc.(b)  39,888  163,142 
Criteo SA sponsored ADR (b)  7,970  142,265 
Discovery Communications, Inc.:     
Class A (a)(b)  26,075  858,911 
Class C (non-vtg.) (b)  54,304  1,657,358 
DISH Network Corp.:     
rights 12/9/19 (b)  1,798  1,223 
Class A (b)  33,372  1,140,321 
Fox Corp.:     
Class A  47,128  1,685,297 
Class B  35,789  1,251,899 
Liberty Broadband Corp.:     
Class A (b)  4,183  494,891 
Class C (b)  25,488  3,045,561 
Liberty Global PLC:     
Class A (b)  25,596  577,190 
Class C (b)  61,699  1,326,529 
Liberty Latin America Ltd. Class A (b)  16,276  289,713 
Liberty Media Corp.:     
Liberty Braves Class C (b)  13,808  390,766 
Liberty Formula One Group Series C (b)  37,874  1,707,739 
Liberty SiriusXM Series A (b)  20,707  1,008,431 
Liberty SiriusXM Series C (b)  29,331  1,422,847 
Loral Space & Communications Ltd. (b)  7,937  268,747 
News Corp.:     
Class A  63,182  813,784 
Class B  32,438  427,208 
Nexstar Broadcasting Group, Inc. Class A  7,430  800,285 
Scholastic Corp.  12,617  468,469 
Sinclair Broadcast Group, Inc. Class A  9,690  337,503 
Sirius XM Holdings, Inc. (a)  628,571  4,387,426 
    66,220,423 
Wireless Telecommunication Services - 0.5%     
Gogo, Inc. (a)(b)  19,192  97,112 
Millicom International Cellular SA (a)  13,582  608,609 
Shenandoah Telecommunications Co.  11,124  417,706 
T-Mobile U.S., Inc. (b)  116,987  9,189,329 
Vodafone Group PLC sponsored ADR  78,949  1,564,769 
    11,877,525 
TOTAL COMMUNICATION SERVICES    317,892,055 
CONSUMER DISCRETIONARY - 10.8%     
Auto Components - 0.1%     
Dorman Products, Inc. (b)  5,869  436,184 
Fox Factory Holding Corp. (a)(b)  9,306  613,545 
Gentex Corp.  52,790  1,499,236 
Gentherm, Inc. (b)  10,408  435,575 
    2,984,540 
Automobiles - 0.4%     
Tesla, Inc. (b)  25,276  8,339,563 
Distributors - 0.2%     
Core-Mark Holding Co., Inc.  13,901  374,632 
LKQ Corp. (b)  55,721  1,965,837 
Pool Corp.  6,579  1,358,235 
    3,698,704 
Diversified Consumer Services - 0.1%     
Career Education Corp. (b)  25,418  423,972 
Frontdoor, Inc. (b)  10,936  494,963 
Grand Canyon Education, Inc. (b)  8,828  752,057 
Strategic Education, Inc.  2,094  296,804 
Weight Watchers International, Inc. (b)  9,128  395,151 
    2,362,947 
Hotels, Restaurants & Leisure - 1.5%     
Bloomin' Brands, Inc.  20,069  482,659 
Caesars Entertainment Corp. (b)  95,321  1,242,986 
Churchill Downs, Inc.  5,681  738,587 
Cracker Barrel Old Country Store, Inc. (a)  2,991  459,836 
Dave & Buster's Entertainment, Inc.  9,962  400,273 
Denny's Corp. (b)  21,499  420,090 
Dunkin' Brands Group, Inc.  13,337  1,020,947 
Eldorado Resorts, Inc. (a)(b)  10,982  587,647 
Golden Entertainment, Inc. (b)  9,766  176,960 
Huazhu Group Ltd. ADR  26,817  917,410 
Jack in the Box, Inc. (a)  4,422  350,620 
Marriott International, Inc. Class A  44,850  6,295,146 
Melco Crown Entertainment Ltd. sponsored ADR  29,734  632,740 
Monarch Casino & Resort, Inc. (b)  6,659  303,650 
Papa John's International, Inc. (a)  5,835  369,239 
Penn National Gaming, Inc. (b)  16,605  382,413 
Playa Hotels & Resorts NV (b)  34,468  271,608 
Ruth's Hospitality Group, Inc.  11,698  273,382 
Scientific Games Corp. Class A (b)  11,223  307,061 
Starbucks Corp.  156,661  13,383,549 
Texas Roadhouse, Inc. Class A  11,765  681,194 
The Cheesecake Factory, Inc. (a)  8,057  351,366 
The Stars Group, Inc. (b)  38,620  937,952 
Wendy's Co.  32,697  701,024 
Wingstop, Inc.  8,051  644,080 
Wynn Resorts Ltd.  12,678  1,532,136 
    33,864,555 
Household Durables - 0.3%     
Cavco Industries, Inc. (b)  2,340  468,023 
Garmin Ltd.  28,864  2,819,724 
GoPro, Inc. Class A (a)(b)  14,299  57,768 
Helen of Troy Ltd. (b)  3,921  632,928 
LGI Homes, Inc. (a)(b)  4,337  313,435 
Newell Brands, Inc.  60,000  1,153,200 
Sonos, Inc. (a)(b)  4,896  67,810 
Universal Electronics, Inc. (b)  5,173  287,619 
    5,800,507 
Internet & Direct Marketing Retail - 6.8%     
Amazon.com, Inc. (b)  65,449  117,860,559 
Baozun, Inc. sponsored ADR (a)(b)  7,042  267,385 
CNOVA NV (a)(b)  49,959  137,612 
Ctrip.com International Ltd. ADR (b)  79,750  2,650,890 
Duluth Holdings, Inc. (a)(b)  13,850  127,836 
eBay, Inc.  108,134  3,840,920 
Etsy, Inc. (b)  24,548  1,065,138 
Expedia, Inc.  24,592  2,500,023 
Groupon, Inc. (b)  74,225  215,253 
JD.com, Inc. sponsored ADR (b)  133,787  4,368,146 
Lands' End, Inc. (a)(b)  10,709  126,152 
MercadoLibre, Inc. (b)  6,737  3,911,367 
Overstock.com, Inc. (a)(b)  11,988  90,989 
PetMed Express, Inc. (a)  7,332  167,390 
Pinduoduo, Inc. ADR (b)  40,482  1,455,328 
Reebonz Holding Ltd. (a)(b)  21,969  26,143 
Secoo Holding Ltd. ADR (b)  2,876  18,263 
Stamps.com, Inc. (b)  3,849  335,825 
Stitch Fix, Inc. (a)(b)  15,033  354,478 
The Booking Holdings, Inc. (b)  5,270  10,034,238 
The RealReal, Inc. (a)  13,134  225,905 
Uxin Ltd. ADR (a)(b)  29,817  74,244 
Waitr Holdings, Inc. (a)(b)  80,026  30,410 
Yunji, Inc. ADR (a)  11,265  44,497 
    149,928,991 
Leisure Products - 0.1%     
Hasbro, Inc.  18,946  1,926,808 
Multiline Retail - 0.2%     
Dollar Tree, Inc. (b)  31,601  2,890,227 
Ollie's Bargain Outlet Holdings, Inc. (a)(b)  11,769  769,693 
    3,659,920 
Specialty Retail - 0.8%     
Bed Bath & Beyond, Inc.  9,120  132,970 
Conn's, Inc. (a)(b)  6,417  140,725 
Five Below, Inc. (b)  9,239  1,142,957 
Monro, Inc.  8,370  614,358 
National Vision Holdings, Inc. (b)  11,255  339,901 
O'Reilly Automotive, Inc. (b)  11,028  4,877,464 
Office Depot, Inc.  48,241  107,577 
Rent-A-Center, Inc.  15,998  416,428 
Ross Stores, Inc.  51,052  5,929,690 
Sleep Number Corp. (b)  11,958  577,213 
The Children's Place Retail Stores, Inc. (a)  3,531  255,150 
Tractor Supply Co.  19,741  1,864,340 
Ulta Beauty, Inc. (b)  8,712  2,037,388 
Urban Outfitters, Inc. (a)(b)  21,640  555,282 
    18,991,443 
Textiles, Apparel & Luxury Goods - 0.3%     
Columbia Sportswear Co.  13,863  1,282,328 
Crocs, Inc. (b)  21,032  734,017 
lululemon athletica, Inc. (b)  19,391  4,376,355 
Sequential Brands Group, Inc. (a)(b)  37,202  14,881 
Steven Madden Ltd.  19,983  848,678 
    7,256,259 
TOTAL CONSUMER DISCRETIONARY    238,814,237 
CONSUMER STAPLES - 3.7%     
Beverages - 1.4%     
Coca-Cola Bottling Co. Consolidated  2,173  587,058 
MGP Ingredients, Inc. (a)  4,818  219,797 
Monster Beverage Corp. (b)  75,518  4,517,487 
National Beverage Corp. (a)  7,202  357,507 
PepsiCo, Inc.  185,479  25,193,613 
    30,875,462 
Food & Staples Retailing - 1.3%     
Casey's General Stores, Inc.  5,990  1,040,882 
Costco Wholesale Corp.  59,770  17,919,644 
Grocery Outlet Holding Corp. (a)  27,142  899,214 
PriceSmart, Inc.  7,246  541,566 
Walgreens Boots Alliance, Inc.  129,975  7,746,510 
    28,147,816 
Food Products - 0.9%     
Beyond Meat, Inc. (a)  7,860  652,066 
Bridgford Foods Corp. (b)  2,905  77,796 
Cal-Maine Foods, Inc. (a)  5,491  239,023 
Calavo Growers, Inc. (a)  4,830  430,788 
Hostess Brands, Inc. Class A (a)(b)  27,665  372,094 
J&J Snack Foods Corp.  2,640  488,400 
Lancaster Colony Corp.  3,608  570,172 
Mondelez International, Inc.  201,306  10,576,617 
Pilgrim's Pride Corp. (b)  35,312  1,112,328 
Sanderson Farms, Inc.  3,521  583,007 
The Kraft Heinz Co.  182,213  5,557,497 
    20,659,788 
Household Products - 0.1%     
Central Garden & Pet Co. Class A (non-vtg.) (b)  10,241  256,127 
WD-40 Co.  3,521  679,940 
    936,067 
Personal Products - 0.0%     
China SXT Pharmaceuticals, Inc. (a)  4,287  3,794 
Inter Parfums, Inc.  8,449  595,570 
    599,364 
TOTAL CONSUMER STAPLES    81,218,497 
ENERGY - 0.2%     
Energy Equipment & Services - 0.0%     
CSI Compressco LP  20,594  50,043 
Geospace Technologies Corp. (b)  5,066  73,052 
KLX Energy Services Holdings, Inc. (b)  14,392  81,315 
Mammoth Energy Services, Inc.  1,996  3,134 
SAExploration Holdings, Inc. (b)  3,479  8,280 
Smart Sand, Inc. (a)(b)  47,491  110,179 
Synthesis Energy Systems, Inc. (a)(b)  1,776  10,052 
    336,055 
Oil, Gas & Consumable Fuels - 0.2%     
Abraxas Petroleum Corp. (b)  62,335  16,020 
Alliance Resource Partners LP  19,929  209,255 
Altus Midstream Co. (b)  31,094  60,011 
Amplify Energy Corp. New warrants 5/4/22 (b)  322 
Berry Petroleum Corp.  15,875  126,524 
Blueknight Energy Partners LP  29,345  31,399 
Calumet Specialty Products Partners LP (b)  5,644  17,440 
Clean Energy Fuels Corp. (b)  82,835  161,528 
Diamondback Energy, Inc.  28,178  2,179,287 
Golar LNG Ltd.  3,550  46,221 
National Energy Services Reunited Corp. (a)(b)  16,343  149,538 
Nextdecade Corp. (a)(b)  23,887  156,460 
Pacific Ethanol, Inc. (b)  15,366  7,436 
Penn Virginia Corp. (b)  7,344  177,358 
Rosehill Resources, Inc. (a)(b)  9,046  10,584 
StealthGas, Inc. (b)  12,758  44,398 
Tellurian, Inc. (a)(b)  40,751  297,075 
Top Ships, Inc. (a)(b)  16,272  12,346 
Viper Energy Partners LP  6,394  151,666 
Westwater Resources, Inc. (a)(b)  5,768  14,939 
    3,869,488 
TOTAL ENERGY    4,205,543 
FINANCIALS - 5.6%     
Banks - 2.3%     
1st Source Corp.  7,466  383,827 
Ameris Bancorp  9,737  425,020 
BancFirst Corp.  8,408  496,829 
Bank OZK  12,921  383,495 
Banner Corp.  8,490  463,809 
BOK Financial Corp.  14,155  1,179,678 
Boston Private Financial Holdings, Inc.  24,137  283,368 
Bridge Bancorp, Inc.  8,138  265,950 
Brookline Bancorp, Inc., Delaware  23,658  379,711 
Camden National Corp.  6,691  290,657 
Cathay General Bancorp  11,462  422,031 
Centerstate Banks of Florida, Inc.  22,089  561,723 
City Holding Co.  4,871  387,147 
Columbia Banking Systems, Inc.  14,067  549,738 
Commerce Bancshares, Inc. (a)  21,771  1,459,310 
Community Trust Bancorp, Inc.  6,566  295,076 
ConnectOne Bancorp, Inc.  11,804  297,343 
CVB Financial Corp.  25,493  544,530 
Eagle Bancorp, Inc.  5,956  264,566 
East West Bancorp, Inc.  26,947  1,234,712 
Enterprise Bancorp, Inc.  1,972  62,887 
Enterprise Financial Services Corp.  7,782  351,746 
Farmers & Merchants Bancorp, Inc.  733  19,021 
Fifth Third Bancorp  132,855  4,010,892 
First Bancorp, North Carolina  9,371  366,406 
First Busey Corp.  13,234  352,024 
First Citizens Bancshares, Inc.  2,215  1,151,357 
First Financial Bancorp, Ohio  8,422  204,823 
First Financial Bankshares, Inc. (a)  29,266  1,011,726 
First Financial Corp., Indiana  5,686  251,435 
First Hawaiian, Inc.  28,859  823,636 
First Internet Bancorp  6,794  154,224 
First Merchants Corp.  3,983  161,272 
First Midwest Bancorp, Inc., Delaware  11,058  238,410 
First of Long Island Corp.  8,401  203,556 
Flushing Financial Corp.  10,762  228,154 
Fulton Financial Corp. (a)  28,336  486,246 
German American Bancorp, Inc.  8,665  292,011 
Glacier Bancorp, Inc.  17,117  750,580 
Great Southern Bancorp, Inc.  5,486  334,811 
Grupo Financiero Galicia SA sponsored ADR  5,193  69,378 
Hancock Whitney Corp.  12,320  500,315 
HarborOne Bancorp, Inc.  25,825  274,003 
Heartland Financial U.S.A., Inc.  8,187  386,590 
Home Bancshares, Inc. (a)  27,393  515,536 
Hope Bancorp, Inc.  12,824  186,076 
Howard Bancorp, Inc. (b)  5,998  99,927 
Huntington Bancshares, Inc.  206,945  3,081,411 
IBERIABANK Corp.  6,842  499,398 
Independent Bank Corp., Massachusetts  9,814  826,339 
Independent Bank Group, Inc.  12,096  697,092 
International Bancshares Corp.  15,319  649,832 
Investar Holding Corp.  1,440  36,029 
Investors Bancorp, Inc.  40,878  492,989 
Lakeland Bancorp, Inc.  16,612  277,088 
Lakeland Financial Corp. (a)  7,498  353,306 
Live Oak Bancshares, Inc. (a)  11,598  211,664 
Mid Penn Bancorp, Inc.  2,455  66,211 
NBT Bancorp, Inc.  12,160  486,400 
Old National Bancorp, Indiana  19,736  356,827 
Opus Bank  11,178  287,386 
Pacific Premier Bancorp, Inc.  12,029  385,409 
PacWest Bancorp  18,529  690,020 
People's Utah Bancorp  8,590  252,117 
Peoples Financial Services Corp.  512  25,149 
Peoples United Financial, Inc.  66,821  1,102,547 
Pinnacle Financial Partners, Inc.  10,341  635,144 
Popular, Inc.  15,282  845,247 
Preferred Bank, Los Angeles  5,343  294,666 
Premier Financial Bancorp, Inc.  914  16,589 
Renasant Corp.  4,476  158,450 
Republic Bancorp, Inc., Kentucky Class A  7,419  342,758 
S&T Bancorp, Inc.  10,063  379,576 
Sandy Spring Bancorp, Inc.  10,430  368,805 
Seacoast Banking Corp., Florida (b)  14,544  432,684 
ServisFirst Bancshares, Inc.  12,746  463,445 
Signature Bank  8,109  1,000,326 
Simmons First National Corp. Class A  16,292  422,126 
South State Corp.  5,528  460,372 
Southside Bancshares, Inc.  10,907  382,945 
Stock Yards Bancorp, Inc.  8,216  340,060 
SVB Financial Group (b)  8,953  2,074,679 
Tcf Financial Corp.  22,145  940,941 
The First Bancorp, Inc.  932  26,543 
TowneBank  6,368  179,259 
Trico Bancshares  8,169  315,732 
Trustmark Corp.  5,565  191,213 
UMB Financial Corp.  9,094  611,753 
Union Bankshares Corp.  6,195  234,171 
United Bankshares, Inc., West Virginia  17,295  654,962 
United Community Bank, Inc.  10,366  321,346 
Univest Corp. of Pennsylvania  11,132  290,657 
Valley National Bancorp  45,929  531,858 
Veritex Holdings, Inc.  10,972  285,382 
Washington Trust Bancorp, Inc.  5,999  313,088 
WesBanco, Inc.  11,223  409,415 
Westamerica Bancorp.  7,186  467,090 
Zions Bancorp NA  31,906  1,588,281 
    50,812,339 
Capital Markets - 1.8%     
Blucora, Inc. (b)  14,901  350,770 
Carlyle Group LP  23,226  692,135 
CME Group, Inc.  60,360  12,236,783 
Diamond Hill Investment Group, Inc.  1,383  188,849 
E*TRADE Financial Corp.  31,769  1,407,367 
Interactive Brokers Group, Inc.  10,175  492,674 
LPL Financial  17,948  1,657,498 
MarketAxess Holdings, Inc.  7,116  2,873,583 
Morningstar, Inc.  8,594  1,350,117 
Northern Trust Corp.  39,141  4,197,481 
SEI Investments Co.  28,612  1,846,332 
T. Rowe Price Group, Inc.  42,361  5,234,125 
TD Ameritrade Holding Corp.  91,002  4,716,634 
The NASDAQ OMX Group, Inc.  29,556  3,097,469 
    40,341,817 
Consumer Finance - 0.2%     
Credit Acceptance Corp. (b)  2,907  1,251,347 
Encore Capital Group, Inc. (a)(b)  5,814  212,037 
First Cash Financial Services, Inc.  6,164  498,298 
Navient Corp.  45,398  651,461 
PRA Group, Inc. (b)  10,276  376,513 
World Acceptance Corp. (b)  2,756  261,792 
    3,251,448 
Insurance - 0.9%     
American National Insurance Co.  4,827  569,586 
Amerisafe, Inc.  6,520  440,752 
Arch Capital Group Ltd. (b)  61,209  2,568,942 
Cincinnati Financial Corp.  25,551  2,735,235 
eHealth, Inc. (b)  9,662  891,416 
Enstar Group Ltd. (b)  2,370  483,978 
Erie Indemnity Co. Class A  9,121  1,544,185 
Fanhua, Inc. ADR (a)  11,228  305,402 
James River Group Holdings Ltd.  9,847  389,547 
Kinsale Capital Group, Inc.  6,945  703,251 
National General Holdings Corp.  17,622  375,172 
National Western Life Group, Inc.  1,109  279,723 
Principal Financial Group, Inc.  45,520  2,508,152 
Safety Insurance Group, Inc.  4,807  469,404 
Selective Insurance Group, Inc.  8,822  584,193 
State Auto Financial Corp.  13,124  430,205 
Trupanion, Inc. (a)(b)  11,408  388,785 
United Fire Group, Inc.  7,944  349,059 
United Insurance Holdings Corp. (a)  16,929  214,829 
Willis Group Holdings PLC  19,271  3,785,595 
    20,017,411 
Mortgage Real Estate Investment Trusts - 0.1%     
AGNC Investment Corp.  86,022  1,489,901 
Thrifts & Mortgage Finance - 0.3%     
Capitol Federal Financial, Inc.  37,201  527,510 
HomeStreet, Inc. (b)  10,502  335,224 
Kearny Financial Corp.  25,496  359,494 
LendingTree, Inc. (a)(b)  1,780  641,743 
Meridian Bancorp, Inc. Maryland  17,463  351,530 
Meta Financial Group, Inc.  9,072  322,691 
NMI Holdings, Inc. (b)  19,949  669,688 
Northfield Bancorp, Inc.  18,186  307,343 
Northwest Bancshares, Inc.  27,448  456,735 
OceanFirst Financial Corp.  14,671  351,811 
TFS Financial Corp.  57,252  1,161,643 
Trustco Bank Corp., New York  35,146  308,582 
Washington Federal, Inc.  10,037  369,462 
WMI Holdings Corp. (b)  14,653  196,936 
WSFS Financial Corp.(a)  15,506  691,413 
    7,051,805 
TOTAL FINANCIALS    122,964,721 
HEALTH CARE - 8.7%     
Biotechnology - 5.0%     
Abeona Therapeutics, Inc. (b)  26,065  87,839 
ACADIA Pharmaceuticals, Inc. (b)  19,620  888,590 
Acceleron Pharma, Inc. (b)  12,360  605,146 
Adamas Pharmaceuticals, Inc. (b)  5,885  35,016 
Adaptimmune Therapeutics PLC sponsored ADR (a)(b)  19,240  22,511 
ADMA Biologics, Inc. (b)  55,419  263,240 
Aduro Biotech, Inc. (b)  17,625  20,974 
Advaxis, Inc. (b)  77,507  39,854 
Aileron Therapeutics, Inc. (b)  36,277  17,417 
Aimmune Therapeutics, Inc. (a)(b)  15,368  429,075 
Alector, Inc.  7,686  143,267 
Alexion Pharmaceuticals, Inc. (b)  31,279  3,563,929 
Allakos, Inc. (a)(b)  4,151  394,345 
Allena Pharmaceuticals, Inc. (a)(b)  7,465  16,498 
Allogene Therapeutics, Inc. (a)(b)  16,096  453,585 
Alnylam Pharmaceuticals, Inc. (b)  14,309  1,676,156 
AMAG Pharmaceuticals, Inc. (a)(b)  7,010  74,657 
Amarin Corp. PLC ADR (a)(b)  49,294  1,048,483 
Amgen, Inc.  80,966  19,004,340 
Amicus Therapeutics, Inc. (b)  29,468  308,825 
AnaptysBio, Inc. (b)  5,651  76,232 
Anika Therapeutics, Inc. (b)  6,083  351,597 
Apellis Pharmaceuticals, Inc. (b)  30,382  816,668 
Aptinyx, Inc. (b)  2,901  11,778 
Aravive, Inc. (b)  6,024  57,951 
Arbutus Biopharma Corp. (b)  33,882  56,583 
Arena Pharmaceuticals, Inc. (b)  10,504  497,680 
Argenx SE ADR (b)  1,815  268,711 
ArQule, Inc. (a)(b)  45,987  441,015 
Arrowhead Pharmaceuticals, Inc. (a)(b)  20,282  1,480,789 
Ascendis Pharma A/S sponsored ADR (b)  7,317  842,772 
Assembly Biosciences, Inc. (b)  7,107  115,276 
Athenex, Inc. (a)(b)  14,410  224,508 
Audentes Therapeutics, Inc. (b)  9,338  271,082 
Autolus Therapeutics Ltd. ADR (b)  3,351  50,265 
Axovant Gene Therapies Ltd. (a)(b)  5,789  31,318 
AzurRx BioPharma, Inc. (b)  11,216  7,404 
BeiGene Ltd. ADR (b)  4,965  1,009,335 
Bellicum Pharmaceuticals, Inc. (a)(b)  55,279  47,938 
BeyondSpring, Inc. (b)  5,009  62,362 
BioCryst Pharmaceuticals, Inc. (b)  9,882  28,164 
Biogen, Inc. (b)  26,835  8,045,401 
BioMarin Pharmaceutical, Inc. (b)  26,303  2,122,915 
bluebird bio, Inc. (b)  8,349  675,768 
Blueprint Medicines Corp. (b)  7,776  637,943 
Calyxt, Inc. (b)  2,539  9,344 
CareDx, Inc. (b)  9,311  191,062 
Cellectis SA sponsored ADR (b)  5,392  74,949 
Chimerix, Inc. (b)  9,221  20,286 
China Biologic Products Holdings, Inc. (a)(b)  4,135  482,182 
Clementia Pharmaceuticals, Inc. rights 12/31/99 (b)(c)  20,215  27,290 
Coherus BioSciences, Inc. (b)  16,242  292,194 
Conatus Pharmaceuticals, Inc. (b)  24,825  9,175 
Constellation Pharmaceuticals, Inc. (b)  893  41,578 
Cortexyme, Inc. (a)  1,411  37,039 
Corvus Pharmaceuticals, Inc. (a)(b)  18,748  57,181 
CRISPR Therapeutics AG (a)(b)  9,272  664,339 
Cyclerion Therapeutics, Inc. (b)  1,643  3,040 
Cytokinetics, Inc. (b)  13,828  133,717 
DBV Technologies SA sponsored ADR (b)  10,232  79,810 
Deciphera Pharmaceuticals, Inc. (b)  15,650  740,089 
Denali Therapeutics, Inc. (a)(b)  34,919  621,209 
Dicerna Pharmaceuticals, Inc. (b)  19,685  473,621 
Dynavax Technologies Corp. (a)(b)  29,347  165,811 
Eagle Pharmaceuticals, Inc. (b)  5,835  341,231 
Editas Medicine, Inc. (a)(b)  10,574  320,181 
Enanta Pharmaceuticals, Inc. (b)  5,202  331,159 
Enochian Biosciences, Inc. (b)  1,009  5,862 
Epizyme, Inc. (b)  7,574  125,122 
Equillium, Inc. (b)  310  998 
Esperion Therapeutics, Inc. (a)(b)  4,081  209,600 
Evelo Biosciences, Inc. (a)(b)  1,946  8,776 
Exact Sciences Corp. (b)  23,500  1,903,735 
Exelixis, Inc. (b)  40,876  679,768 
Fate Therapeutics, Inc. (b)  16,681  260,557 
FibroGen, Inc. (b)  15,284  647,583 
Five Prime Therapeutics, Inc. (b)  16,392  64,257 
Forty Seven, Inc. (b)  3,157  39,904 
G1 Therapeutics, Inc. (a)(b)  8,681  187,510 
Galmed Pharmaceuticals Ltd. (a)(b)  2,534  11,403 
Gilead Sciences, Inc.  170,486  11,463,479 
Global Blood Therapeutics, Inc. (b)  8,238  547,827 
Gossamer Bio, Inc.  8,682  221,391 
Grifols SA ADR  31,052  710,470 
Gritstone Oncology, Inc. (a)(b)  11,234  97,848 
Halozyme Therapeutics, Inc. (b)  27,194  527,292 
Heron Therapeutics, Inc. (b)  10,665  272,597 
Idera Pharmaceuticals, Inc. (b)  3,185  5,574 
ImmunoGen, Inc. (b)  157,382  568,149 
Immunomedics, Inc. (a)(b)  33,152  622,595 
Incyte Corp. (b)  25,340  2,386,014 
InflaRx NV (a)(b)  15,355  52,207 
Insmed, Inc. (b)  12,450  286,973 
Intec Pharma Ltd. (a)(b)  13,375  6,637 
Ionis Pharmaceuticals, Inc. (b)  21,415  1,369,703 
Iovance Biotherapeutics, Inc. (a)(b)  48,587  1,109,241 
Jounce Therapeutics, Inc. (b)  3,780  20,450 
Karyopharm Therapeutics, Inc. (b)  63,810  1,117,951 
Kiniksa Pharmaceuticals Ltd. (b)  7,395  78,757 
La Jolla Pharmaceutical Co. (a)(b)  40,301  110,425 
Ligand Pharmaceuticals, Inc.:     
Class B (a)(b)  3,077  347,701 
General CVR (b)  1,530 
Glucagon CVR (b)  1,530  61 
rights (b)  1,530 
TR Beta CVR (b)  1,530  317 
Magenta Therapeutics, Inc. (b)  4,524  59,898 
Marker Therapeutics, Inc. (a)(b)  17,902  59,793 
Mersana Therapeutics, Inc. (b)  8,765  33,745 
Midatech Pharma PLC ADR (b)  9,991  6,494 
Mirati Therapeutics, Inc. (b)  6,110  615,705 
Moderna, Inc.  46,349  943,666 
Momenta Pharmaceuticals, Inc. (b)  14,640  245,952 
Myriad Genetics, Inc. (b)  17,855  459,588 
Natera, Inc. (b)  17,618  642,881 
Neoleukin Therapeutics, Inc. (b)  4,418  24,652 
Neon Therapeutics, Inc. (b)  5,701  6,499 
Neurocrine Biosciences, Inc. (b)  17,132  1,997,763 
Novavax, Inc. (a)(b)  11,347  55,033 
NuCana PLC ADR (a)(b)  3,114  26,656 
ObsEva SA (b)  7,154  32,551 
Organogenesis Holdings, Inc. Class A (b)  1,696  8,700 
Portola Pharmaceuticals, Inc. (b)  4,571  130,502 
Precision BioSciences, Inc. (a)(b)  5,859  104,114 
ProQR Therapeutics BV (b)  3,756  32,076 
Proteostasis Therapeutics, Inc. (a)(b)  82,725  201,849 
Prothena Corp. PLC (b)  2,942  37,716 
PTC Therapeutics, Inc. (b)  11,883  558,026 
Ra Pharmaceuticals, Inc. (b)  26,540  1,240,214 
Regeneron Pharmaceuticals, Inc. (b)  15,129  5,582,601 
REGENXBIO, Inc. (b)  8,750  366,275 
Repligen Corp. (b)  12,035  1,068,106 
Rocket Pharmaceuticals, Inc. (a)(b)  18,856  331,677 
Sage Therapeutics, Inc. (b)  6,862  1,062,032 
Sangamo Therapeutics, Inc. (b)  17,669  190,825 
Sarepta Therapeutics, Inc. (a)(b)  11,146  1,253,814 
Savara, Inc. (a)(b)  24,966  31,457 
Seattle Genetics, Inc. (b)  24,668  2,968,794 
Selecta Biosciences, Inc. (b)  6,484  10,634 
Sellas Life Sciences Group, Inc. (a)(b)  1,538  7,075 
Seres Therapeutics, Inc. (b)  32,169  127,068 
Solid Biosciences, Inc. (a)(b)  11,389  44,759 
Spark Therapeutics, Inc. (b)  6,090  676,843 
Sunesis Pharmaceuticals, Inc. (b)  28,734  12,356 
Synlogic, Inc. (b)  18,534  39,663 
T2 Biosystems, Inc. (a)(b)  51,707  70,322 
TG Therapeutics, Inc. (a)(b)  1,483  12,146 
The Medicines Company (a)(b)  14,322  1,205,912 
Tobira Therapeutics, Inc. rights (b)(c)  1,750  14,403 
Tocagen, Inc. (a)(b)  22,216  14,551 
Translate Bio, Inc. (a)(b)  12,744  128,077 
Tyme, Inc. (a)(b)  7,312  8,263 
uniQure B.V. (a)(b)  15,260  849,372 
UNITY Biotechnology, Inc. (b)  2,928  22,604 
VBI Vaccines, Inc. (b)  40,407  36,298 
Verastem, Inc. (a)(b)  103,955  142,418 
Vertex Pharmaceuticals, Inc. (b)  34,937  7,747,280 
Viking Therapeutics, Inc. (a)(b)  14,111  103,293 
Voyager Therapeutics, Inc. (b)  28,263  385,507 
Xencor, Inc. (b)  13,328  525,123 
Xenetic Biosciences, Inc. (a)(b)  19,052  23,434 
Zafgen, Inc. (a)(b)  14,542  11,779 
ZIOPHARM Oncology, Inc. (a)(b)  22,688  118,204 
    111,227,469 
Health Care Equipment & Supplies - 1.8%     
Abiomed, Inc. (b)  7,504  1,472,135 
Align Technology, Inc. (b)  11,373  3,154,188 
Atrion Corp.  503  354,464 
Cardiovascular Systems, Inc. (b)  12,741  580,480 
CONMED Corp.  7,477  846,920 
Dentsply Sirona, Inc.  37,588  2,125,226 
DexCom, Inc. (b)  14,661  3,332,592 
electroCore, Inc. (a)(b)  9,670  14,602 
Heska Corp. (b)  2,242  214,111 
Hologic, Inc. (b)  48,175  2,472,341 
ICU Medical, Inc. (b)  2,953  553,628 
IDEXX Laboratories, Inc. (b)  11,421  2,873,295 
Insulet Corp. (b)  10,204  1,894,883 
Integra LifeSciences Holdings Corp. (b)  12,114  738,833 
Intuitive Surgical, Inc. (b)  15,605  9,252,205 
iRhythm Technologies, Inc. (b)  6,670  480,840 
Lantheus Holdings, Inc. (b)  8,092  169,123 
LeMaitre Vascular, Inc. (a)  7,846  279,082 
LivaNova PLC (b)  7,781  651,737 
Masimo Corp. (b)  7,474  1,158,993 
Merit Medical Systems, Inc. (b)  9,961  278,908 
Natus Medical, Inc. (b)  14,984  479,338 
Neogen Corp. (b)  10,214  679,946 
Novocure Ltd. (b)  15,576  1,435,796 
NuVasive, Inc. (b)  8,026  579,798 
Orthofix International NV (b)  5,544  251,698 
Quidel Corp. (b)  8,778  602,346 
Sientra, Inc. (b)  3,197  27,366 
Tactile Systems Technology, Inc. (a)(b)  5,345  343,202 
Tandem Diabetes Care, Inc. (b)  10,396  717,636 
Varex Imaging Corp. (b)  11,076  331,615 
Wright Medical Group NV (b)  17,877  532,198 
    38,879,525 
Health Care Providers & Services - 0.4%     
Amedisys, Inc. (b)  7,234  1,178,853 
BioScrip, Inc. (b)  30,832  95,888 
BioTelemetry, Inc. (b)  11,159  516,773 
Corvel Corp. (b)  6,279  518,080 
Guardant Health, Inc. (b)  13,092  1,016,856 
HealthEquity, Inc. (b)  10,588  665,879 
Henry Schein, Inc. (b)  18,797  1,295,113 
LHC Group, Inc. (b)  3,230  430,882 
Magellan Health Services, Inc. (b)  4,031  313,330 
National Research Corp. Class A  9,098  586,912 
Patterson Companies, Inc.  7,241  140,910 
Pennant Group, Inc. (b)  7,515  176,001 
Premier, Inc. (b)  8,746  310,833 
Surgery Partners, Inc. (a)(b)  16,713  230,305 
The Ensign Group, Inc.  15,031  652,796 
    8,129,411 
Health Care Technology - 0.2%     
Allscripts Healthcare Solutions, Inc. (b)  17,799  191,873 
Cerner Corp.  43,266  3,097,413 
HMS Holdings Corp. (b)  24,142  729,088 
Inovalon Holdings, Inc. Class A (a)(b)  21,106  379,908 
Livongo Health, Inc. (a)  3,012  86,023 
NantHealth, Inc. (a)(b)  17,512  20,664 
Nextgen Healthcare, Inc. (b)  23,055  424,673 
Omnicell, Inc. (b)  10,439  835,016 
    5,764,658 
Life Sciences Tools & Services - 0.7%     
Accelerate Diagnostics, Inc. (a)(b)  11,370  169,868 
Bio-Techne Corp.  7,421  1,619,633 
Bruker Corp.  25,599  1,310,413 
ICON PLC (b)  8,537  1,392,897 
Illumina, Inc. (b)  20,267  6,500,843 
Luminex Corp.  15,648  330,642 
Medpace Holdings, Inc. (b)  10,794  827,576 
NeoGenomics, Inc. (b)  34,982  902,885 
Pacific Biosciences of California, Inc. (b)  35,678  183,385 
PRA Health Sciences, Inc. (b)  9,052  984,948 
Syneos Health, Inc. (b)  16,839  924,629 
    15,147,719 
Pharmaceuticals - 0.6%     
Aclaris Therapeutics, Inc. (a)(b)  40,091  65,749 
Akcea Therapeutics, Inc. (a)(b)  15,080  293,608 
Akorn, Inc. (b)  68,795  251,102 
Amphastar Pharmaceuticals, Inc. (b)  15,717  306,639 
ANI Pharmaceuticals, Inc. rights (b)(c)  739 
Aquestive Therapeutics, Inc. (a)(b)  5,107  39,784 
AstraZeneca PLC rights (b)(c)  1,845 
Axsome Therapeutics, Inc. (a)(b)  10,341  407,125 
ContraVir Pharmaceuticals, Inc. (a)(b)  3,018  21,096 
Corcept Therapeutics, Inc. (a)(b)  22,397  287,354 
Cronos Group, Inc. (b)  25,285  173,034 
CymaBay Therapeutics, Inc. (b)  3,400  5,984 
Dova Pharmaceuticals, Inc. rights 12/31/99 (b)(c)  7,729  4,174 
Eloxx Pharmaceuticals, Inc. (b)  3,468  18,103 
Evolus, Inc. (a)(b)  15,964  223,336 
GW Pharmaceuticals PLC ADR (a)(b)  4,305  439,584 
Horizon Pharma PLC (b)  30,058  985,301 
Innoviva, Inc. (b)  22,119  298,164 
Jazz Pharmaceuticals PLC (b)  9,754  1,474,024 
Kala Pharmaceuticals, Inc. (a)(b)  5,409  22,556 
Marinus Pharmaceuticals, Inc. (b)  8,526  11,254 
Melinta Therapeutics, Inc. (a)(b)  52,897  85,693 
Mylan NV (b)  76,598  1,438,510 
MyoKardia, Inc. (b)  7,375  480,481 
Omeros Corp. (a)(b)  7,912  117,098 
Pacira Biosciences, Inc. (b)  7,519  347,528 
Paratek Pharmaceuticals, Inc. (a)(b)  16,470  48,257 
Provention Bio, Inc. (b)  1,695  16,882 
Reata Pharmaceuticals, Inc. (b)  6,255  1,220,538 
Sanofi SA sponsored ADR  36,560  1,706,621 
Sienna Biopharmaceuticals, Inc. (b)  50,412  8,484 
Supernus Pharmaceuticals, Inc. (b)  11,379  266,041 
Tetraphase Pharmaceuticals, Inc. (b)  6,142  15,969 
Tilray, Inc. Class 2 (a)(b)  13,445  266,749 
Tricida, Inc. (a)(b)  14,808  591,728 
WAVE Life Sciences (a)(b)  7,138  236,625 
Zogenix, Inc. (b)  16,277  777,715 
    12,952,890 
TOTAL HEALTH CARE    192,101,672 
INDUSTRIALS - 3.9%     
Aerospace & Defense - 0.2%     
AeroVironment, Inc. (b)  2,840  174,206 
Axon Enterprise, Inc. (a)(b)  11,906  878,663 
Elbit Systems Ltd. (a)  7,954  1,314,796 
Kratos Defense & Security Solutions, Inc. (b)  26,079  470,987 
Mercury Systems, Inc. (b)  9,884  724,003 
    3,562,655 
Air Freight & Logistics - 0.2%     
Air Transport Services Group, Inc. (b)  17,366  427,377 
C.H. Robinson Worldwide, Inc.  21,607  1,660,498 
Expeditors International of Washington, Inc.  26,800  2,003,568 
Forward Air Corp.  8,008  560,800 
Hub Group, Inc. Class A (b)  9,910  506,104 
    5,158,347 
Airlines - 0.4%     
Allegiant Travel Co.  3,240  549,925 
American Airlines Group, Inc.  62,562  1,798,032 
Hawaiian Holdings, Inc.  9,169  277,729 
JetBlue Airways Corp. (b)  46,572  897,442 
Ryanair Holdings PLC sponsored ADR (b)  17,697  1,474,514 
SkyWest, Inc.  10,525  659,286 
United Continental Holdings, Inc. (b)  42,550  3,948,640 
    9,605,568 
Building Products - 0.1%     
AAON, Inc. (a)  22,610  1,116,256 
American Woodmark Corp. (b)  2,303  236,979 
Apogee Enterprises, Inc.  6,691  255,864 
Builders FirstSource, Inc. (b)  9,994  253,948 
Caesarstone Sdot-Yam Ltd.  4,264  66,774 
Gibraltar Industries, Inc. (b)  9,690  506,012 
Patrick Industries, Inc.  6,934  343,372 
Universal Forest Products, Inc.  4,857  240,907 
    3,020,112 
Commercial Services & Supplies - 0.6%     
Casella Waste Systems, Inc. Class A (b)  13,682  639,086 
Cimpress NV (a)(b)  5,617  719,762 
Cintas Corp.  14,119  3,629,430 
Copart, Inc. (b)  35,573  3,165,997 
Healthcare Services Group, Inc. (a)  8,245  207,362 
Herman Miller, Inc.  24,781  1,184,036 
Interface, Inc.  16,835  282,660 
Kimball International, Inc. Class B  15,676  335,153 
McGrath RentCorp.  7,252  531,862 
Mobile Mini, Inc.  11,443  434,376 
SP Plus Corp. (b)  8,683  380,750 
Stericycle, Inc. (a)(b)  10,264  644,784 
Tetra Tech, Inc.  6,229  549,958 
U.S. Ecology, Inc.  6,286  345,667 
    13,050,883 
Construction & Engineering - 0.0%     
Aegion Corp. (b)  13,315  288,403 
Concrete Pumping Holdings, Inc. (b)  4,220  20,256 
Primoris Services Corp.  14,399  317,066 
    625,725 
Electrical Equipment - 0.1%     
Ballard Power Systems, Inc. (a)(b)  43,500  288,515 
Encore Wire Corp.  6,572  383,410 
Sunrun, Inc. (b)  27,893  387,155 
TPI Composites, Inc. (a)(b)  10,051  181,421 
    1,240,501 
Industrial Conglomerates - 0.1%     
Icahn Enterprises LP  28,345  1,785,735 
Raven Industries, Inc.  10,360  356,073 
    2,141,808 
Machinery - 0.6%     
Altra Industrial Motion Corp.  8,607  282,912 
Astec Industries, Inc.  2,611  97,808 
Chart Industries, Inc. (b)  7,890  435,528 
Columbus McKinnon Corp. (NY Shares)  7,901  324,573 
Franklin Electric Co., Inc.  20,107  1,115,335 
Kornit Digital Ltd. (a)(b)  7,836  267,208 
Lincoln Electric Holdings, Inc.  9,344  862,077 
Middleby Corp. (b)  8,488  982,571 
Nordson Corp.  8,524  1,413,535 
Omega Flex, Inc.  3,896  373,276 
PACCAR, Inc.  46,414  3,776,707 
RBC Bearings, Inc. (b)  2,794  463,469 
Sun Hydraulics Corp.  17,236  771,828 
TriMas Corp. (b)  13,891  430,343 
Woodward, Inc.  8,000  934,320 
    12,531,490 
Marine - 0.0%     
Golden Ocean Group Ltd.  46,185  278,497 
Seanergy Martime Holdings Corp. (b)  13,843  7,323 
Star Bulk Carriers Corp. (a)  26,391  290,037 
    575,857 
Professional Services - 0.5%     
51job, Inc. sponsored ADR (b)  6,921  544,129 
CoStar Group, Inc. (b)  6,192  3,794,829 
Exponent, Inc.  5,730  364,142 
Forrester Research, Inc.  6,825  272,522 
Huron Consulting Group, Inc. (b)  7,834  525,270 
ICF International, Inc.  5,851  525,010 
Kelly Services, Inc. Class A (non-vtg.)  12,016  263,271 
Upwork, Inc. (b)  14,778  172,164 
Verisk Analytics, Inc.  21,761  3,209,312 
    9,670,649 
Road & Rail - 0.9%     
AMERCO  2,785  1,008,783 
ArcBest Corp.  8,866  255,163 
Avis Budget Group, Inc. (b)  13,338  396,806 
CSX Corp.  110,683  7,918,262 
Heartland Express, Inc.  23,678  506,946 
J.B. Hunt Transport Services, Inc.  14,122  1,632,786 
Landstar System, Inc.  5,345  595,486 
Lyft, Inc. (a)  46,247  2,265,178 
Marten Transport Ltd.  16,558  349,871 
Old Dominion Freight Lines, Inc.  12,570  2,408,286 
Saia, Inc. (b)  6,693  635,166 
Universal Logistics Holdings, Inc.  11,720  233,697 
Werner Enterprises, Inc.  9,950  365,762 
    18,572,192 
Trading Companies & Distributors - 0.2%     
Beacon Roofing Supply, Inc. (b)  5,730  169,895 
BMC Stock Holdings, Inc. (b)  19,956  590,897 
Fastenal Co.  73,586  2,613,775 
H&E Equipment Services, Inc.  6,985  230,505 
HD Supply Holdings, Inc. (b)  27,390  1,090,670 
Rush Enterprises, Inc. Class A  9,758  447,112 
    5,142,854 
TOTAL INDUSTRIALS    84,898,641 
INFORMATION TECHNOLOGY - 33.7%     
Communications Equipment - 1.6%     
Acacia Communications, Inc. (b)  10,239  682,327 
Applied Optoelectronics, Inc. (a)(b)  7,379  78,955 
Cisco Systems, Inc.  611,455  27,705,026 
EchoStar Holding Corp. Class A (b)  8,139  342,408 
Ericsson (B Shares) sponsored ADR  75,352  681,182 
Extreme Networks, Inc. (b)  11,842  83,249 
F5 Networks, Inc. (b)  9,116  1,328,292 
InterDigital, Inc.  4,992  283,546 
Ituran Location & Control Ltd.  8,722  209,328 
Lumentum Holdings, Inc. (b)  13,600  1,001,776 
NETGEAR, Inc. (b)  8,205  206,028 
Radware Ltd. (b)  15,361  370,046 
Sierra Wireless, Inc. (b)  8,475  74,714 
ViaSat, Inc. (b)  8,689  638,642 
Viavi Solutions, Inc. (b)  42,482  638,080 
xG Technology, Inc. (a)(b)  27,712  7,482 
    34,331,081 
Electronic Equipment & Components - 1.0%     
Avnet, Inc.  17,526  712,432 
CDW Corp.  23,106  3,120,465 
Cognex Corp. (a)  27,363  1,373,075 
Coherent, Inc. (b)  2,824  426,029 
ePlus, Inc. (b)  4,490  375,229 
Flextronics International Ltd. (b)  63,644  755,454 
FLIR Systems, Inc.  23,089  1,236,647 
Hollysys Automation Technologies Ltd.  17,122  251,865 
II-VI, Inc. (b)  16,373  477,928 
Insight Enterprises, Inc. (b)  9,824  644,356 
IPG Photonics Corp. (b)  7,545  1,072,069 
Itron, Inc. (b)  12,724  1,018,938 
Littelfuse, Inc.  3,525  639,470 
MTS Systems Corp.  6,119  277,925 
National Instruments Corp.  25,082  1,056,454 
Novanta, Inc. (b)  8,758  816,070 
OSI Systems, Inc. (b)  5,680  565,103 
PC Connection, Inc.  9,806  483,632 
Plexus Corp. (b)  8,581  651,298 
Sanmina Corp. (b)  18,352  583,777 
ScanSource, Inc. (b)  9,349  331,142 
Tech Data Corp. (b)  5,577  808,052 
Trimble, Inc. (b)  44,098  1,787,292 
TTM Technologies, Inc. (b)  28,779  385,926 
Zebra Technologies Corp. Class A (b)  8,651  2,170,882 
    22,021,510 
IT Services - 3.2%     
21Vianet Group, Inc. ADR (b)  2,069  14,007 
Akamai Technologies, Inc. (b)  28,846  2,513,064 
Amdocs Ltd.  24,602  1,704,919 
Automatic Data Processing, Inc.  59,917  10,232,625 
Carbonite, Inc. (b)  10,729  246,767 
Cardtronics PLC (a)(b)  9,737  411,096 
Cass Information Systems, Inc.  5,786  326,735 
Cognizant Technology Solutions Corp. Class A  80,142  5,137,904 
CSG Systems International, Inc.  9,450  540,446 
Euronet Worldwide, Inc. (b)  6,915  1,086,969 
Exela Technologies, Inc. (b)  45,334  14,684 
ExlService Holdings, Inc. (b)  8,789  613,560 
Fiserv, Inc. (b)  95,468  11,097,200 
GDS Holdings Ltd. ADR (a)(b)  13,712  641,996 
GreenSky, Inc. Class A (a)(b)  4,432  32,974 
Inpixon (b)  135,997  5,685 
Internap Network Services Corp. (a)(b)  3,381  4,057 
Jack Henry & Associates, Inc.  14,008  2,128,376 
ManTech International Corp. Class A  5,357  415,596 
MongoDB, Inc. Class A (b)  6,743  1,002,684 
NIC, Inc.  22,752  516,243 
Okta, Inc. (b)  16,178  2,099,581 
Paychex, Inc.  47,150  4,060,558 
PayPal Holdings, Inc. (b)  156,477  16,901,081 
Presidio, Inc.  26,569  438,654 
QIWI PLC Class B sponsored ADR  10,597  210,033 
Sabre Corp.  41,551  931,989 
StoneCo Ltd. Class A (a)(b)  18,347  751,860 
Sykes Enterprises, Inc. (b)  13,286  466,870 
Ttec Holdings, Inc.  12,755  585,837 
Tucows, Inc. (a)(b)  4,804  272,627 
VeriSign, Inc. (b)  18,972  3,618,719 
Virtusa Corp. (b)  8,785  392,602 
Wix.com Ltd. (b)  7,857  949,833 
    70,367,831 
Semiconductors & Semiconductor Equipment - 8.3%     
Advanced Energy Industries, Inc. (b)  6,263  402,147 
Advanced Micro Devices, Inc. (b)  155,002  6,068,328 
Ambarella, Inc. (b)  6,719  367,798 
Amkor Technology, Inc. (b)  24,549  296,797 
Analog Devices, Inc.  49,516  5,592,832 
Applied Materials, Inc.  130,428  7,551,781 
ASML Holding NV (a)  10,742  2,907,000 
Axcelis Technologies, Inc. (b)  9,692  207,796 
Broadcom, Inc.  54,530  17,242,931 
Brooks Automation, Inc.  17,887  800,801 
Cabot Microelectronics Corp.  4,539  605,548 
Canadian Solar, Inc. (b)  20,477  334,799 
Ceva, Inc. (b)  4,587  118,895 
Cirrus Logic, Inc. (b)  6,013  431,132 
Cree, Inc. (b)  16,213  716,777 
Cypress Semiconductor Corp.  58,475  1,371,239 
Diodes, Inc. (b)  13,993  645,637 
Enphase Energy, Inc. (a)(b)  40,062  876,156 
Entegris, Inc.  24,164  1,143,440 
First Solar, Inc. (b)  13,181  728,118 
FormFactor, Inc. (b)  25,137  581,670 
Himax Technologies, Inc. sponsored ADR (a)(b)  17,791  40,919 
Intel Corp.  623,049  36,167,994 
KLA-Tencor Corp.  22,270  3,649,162 
Kopin Corp. (b)  22,389  11,277 
Kulicke & Soffa Industries, Inc.  18,277  458,570 
Lam Research Corp.  21,828  5,824,365 
Lattice Semiconductor Corp. (b)  49,276  930,824 
Marvell Technology Group Ltd.  108,451  2,859,853 
Maxim Integrated Products, Inc.  38,600  2,187,462 
Mellanox Technologies Ltd. (b)  8,693  998,826 
Microchip Technology, Inc. (a)  30,605  2,893,397 
Micron Technology, Inc. (b)  159,314  7,569,008 
MKS Instruments, Inc.  8,266  878,510 
Monolithic Power Systems, Inc.  6,473  1,040,082 
Nova Measuring Instruments Ltd. (b)  11,360  410,323 
NVIDIA Corp.  87,192  18,897,994 
NXP Semiconductors NV  39,790  4,598,928 
ON Semiconductor Corp. (b)  73,501  1,578,066 
Power Integrations, Inc. (a)  3,671  335,860 
Qorvo, Inc. (b)  19,591  2,041,578 
Qualcomm, Inc.  165,676  13,842,230 
Rambus, Inc. (b)  30,226  394,449 
Semtech Corp. (b)  14,685  711,635 
Silicon Laboratories, Inc. (b)  8,027  850,300 
Silicon Motion Technology Corp. sponsored ADR  9,580  424,394 
Skyworks Solutions, Inc.  25,151  2,472,343 
SolarEdge Technologies, Inc. (b)  7,947  648,555 
SunPower Corp. (a)(b)  18,208  136,378 
Synaptics, Inc. (a)(b)  8,320  475,571 
Teradyne, Inc.  25,473  1,594,355 
Texas Instruments, Inc.  123,547  14,851,585 
Tower Semiconductor Ltd. (b)  11,788  258,393 
Universal Display Corp.  7,172  1,392,946 
Xilinx, Inc.  34,380  3,189,776 
Xperi Corp.  8,775  173,657 
    183,781,187 
Software - 11.9%     
ACI Worldwide, Inc. (b)  22,881  858,038 
Adobe, Inc. (b)  68,494  21,200,948 
Alarm.com Holdings, Inc. (b)  11,706  510,616 
ANSYS, Inc. (b)  15,102  3,846,328 
Aspen Technology, Inc. (b)  13,746  1,723,748 
Atlassian Corp. PLC (b)  18,747  2,382,931 
Autodesk, Inc. (b)  30,275  5,476,748 
Blackbaud, Inc.  9,620  797,306 
BlackLine, Inc. (a)(b)  12,735  685,398 
Bottomline Technologies, Inc. (b)  9,873  488,615 
Cadence Design Systems, Inc. (b)  36,719  2,579,510 
CDK Global, Inc.  24,482  1,311,011 
Cerence, Inc. (b)  5,915  92,037 
Check Point Software Technologies Ltd. (b)  22,700  2,675,876 
Citrix Systems, Inc.  19,842  2,238,376 
CommVault Systems, Inc. (b)  7,179  363,401 
Cornerstone OnDemand, Inc. (b)  13,451  829,523 
Coupa Software, Inc. (b)  11,657  1,789,233 
Crowdstrike Holdings, Inc. (a)  3,235  187,630 
CyberArk Software Ltd. (b)  8,518  1,043,881 
Descartes Systems Group, Inc. (Canada) (b)  18,602  796,848 
DocuSign, Inc. (b)  23,030  1,639,966 
Dropbox, Inc. Class A (b)  27,891  515,705 
Ebix, Inc. (a)  5,943  206,698 
Everbridge, Inc. (b)  8,739  768,508 
FireEye, Inc. (b)  19,899  333,507 
Five9, Inc. (b)  14,650  998,691 
Fortinet, Inc. (b)  30,678  3,224,565 
GTY Govtech, Inc. (a)(b)  16,632  81,996 
Ideanomics, Inc. (a)(b)  17,035  15,507 
Intuit, Inc.  35,405  9,166,000 
j2 Global, Inc.  10,291  998,433 
LivePerson, Inc. (b)  18,911  750,578 
Magic Software Enterprises Ltd.  7,487  75,694 
Manhattan Associates, Inc. (b)  12,458  1,040,368 
Microsoft Corp.  1,014,248  153,536,862 
MicroStrategy, Inc. Class A (b)  2,933  440,918 
Mimecast Ltd. (b)  14,598  647,421 
NICE Systems Ltd. sponsored ADR (a)(b)  8,888  1,346,443 
Nortonlifelock, Inc.  83,613  2,081,964 
Nuance Communications, Inc. (b)  47,328  848,591 
Nutanix, Inc. Class A (b)  32,826  1,226,051 
Open Text Corp.  49,393  2,153,019 
Parametric Technology Corp. (b)  21,592  1,653,947 
Paylocity Holding Corp. (b)  10,359  1,267,113 
Pegasystems, Inc.  15,075  1,170,122 
Phunware, Inc. (b)  3,266  4,180 
Pluralsight, Inc. (b)  15,026  255,292 
Progress Software Corp.  12,316  517,395 
Proofpoint, Inc. (b)  7,947  943,229 
Qualys, Inc. (b)  7,927  693,692 
Rapid7, Inc. (b)  12,937  725,378 
RealPage, Inc. (b)  13,411  738,007 
Sapiens International Corp. NV  24,692  555,817 
SecureWorks Corp. (b)  3,376  38,284 
Splunk, Inc. (b)  24,814  3,702,745 
SPS Commerce, Inc. (b)  10,241  576,876 
SS&C Technologies Holdings, Inc.  42,429  2,547,861 
SurveyMonkey (b)  14,374  245,364 
Synopsys, Inc. (b)  22,026  3,106,547 
Talend SA ADR (a)(b)  7,575  287,547 
Tenable Holdings, Inc. (b)  9,447  256,486 
The Trade Desk, Inc. (a)(b)  5,520  1,453,637 
TiVo Corp.  27,730  216,571 
Varonis Systems, Inc. (b)  7,241  565,595 
Verint Systems, Inc. (b)  11,734  570,390 
Veritone, Inc. (a)(b)  4,013  12,119 
Workday, Inc. Class A (b)  21,702  3,887,262 
Xunlei Ltd. sponsored ADR (a)(b)  21,053  108,844 
Zoom Video Communications, Inc. Class A  8,041  599,055 
Zscaler, Inc. (a)(b)  20,062  1,045,832 
    261,720,674 
Technology Hardware, Storage & Peripherals - 7.7%     
Apple, Inc.  600,169  160,395,143 
Logitech International SA  32,045  1,395,880 
Nano Dimension Ltd. ADR (a)(b)  15,006  39,016 
NetApp, Inc.  50,846  3,080,759 
Seagate Technology LLC  48,079  2,869,355 
Sonim Technologies, Inc. (a)  4,524  12,577 
Stratasys Ltd. (a)(b)  16,512  304,481 
Western Digital Corp.  48,553  2,443,672 
    170,540,883 
TOTAL INFORMATION TECHNOLOGY    742,763,166 
MATERIALS - 0.3%     
Chemicals - 0.1%     
A. Schulman, Inc. rights (b)(c)  7,892  3,417 
AgroFresh Solutions, Inc. (b)  3,504  8,304 
Amyris, Inc. (a)(b)  31,579  126,948 
Balchem Corp.  3,264  325,192 
Innophos Holdings, Inc.  4,234  135,065 
Innospec, Inc.  6,694  658,690 
Loop Industries, Inc. (a)(b)  4,881  49,786 
    1,307,402 
Containers & Packaging - 0.0%     
Silgan Holdings, Inc.  12,356  380,688 
Metals & Mining - 0.2%     
Century Aluminum Co. (b)  7,673  54,095 
Ferroglobe PLC (b)  34,193  21,839 
Ferroglobe Representation & Warranty Insurance (b)(c)  7,187 
Kaiser Aluminum Corp.  4,316  472,947 
Pan American Silver Corp.  27,633  531,935 
Royal Gold, Inc.  10,065  1,180,323 
Schnitzer Steel Industries, Inc. Class A  10,194  219,681 
SSR Mining, Inc. (b)  26,867  420,309 
Steel Dynamics, Inc.  35,302  1,190,736 
    4,091,865 
Paper & Forest Products - 0.0%     
Mercer International, Inc. (SBI)  23,694  296,886 
TOTAL MATERIALS    6,076,841 
REAL ESTATE - 1.1%     
Equity Real Estate Investment Trusts (REITs) - 1.0%     
Brookfield Property REIT, Inc. Class A  10,568  201,003 
CareTrust (REIT), Inc.  25,480  532,022 
CIM Commercial Trust Corp.  6,063  87,914 
CyrusOne, Inc.  16,047  999,728 
Equinix, Inc.  14,253  8,079,313 
Gaming & Leisure Properties  38,655  1,631,241 
Hospitality Properties Trust (SBI)  22,995  535,554 
Industrial Logistics Properties Trust  9,225  199,629 
Lamar Advertising Co. Class A  13,635  1,137,568 
Potlatch Corp.  10,141  440,424 
Regency Centers Corp.  25,398  1,651,886 
Retail Opportunity Investments Corp.  28,361  517,305 
Sabra Health Care REIT, Inc.  20,156  449,076 
SBA Communications Corp. Class A  20,964  4,957,357 
    21,420,020 
Real Estate Management & Development - 0.1%     
Brookfield Property Partners LP  69,333  1,321,101 
Colliers International Group, Inc.  8,226  594,826 
FirstService Corp.  8,143  780,832 
Newmark Group, Inc.  27,138  354,151 
Redfin Corp. (a)(b)  2,946  56,799 
The RMR Group, Inc.  4,874  228,932 
    3,336,641 
TOTAL REAL ESTATE    24,756,661 
UTILITIES - 0.8%     
Electric Utilities - 0.7%     
Alliant Energy Corp.  39,645  2,101,185 
Exelon Corp.  132,605  5,887,662 
MGE Energy, Inc. (a)  8,849  685,974 
Otter Tail Corp.  10,606  521,391 
Xcel Energy, Inc.  74,350  4,571,782 
    13,767,994 
Independent Power and Renewable Electricity Producers - 0.1%     
Atlantica Yield PLC  18,662  483,719 
Pattern Energy Group, Inc.  23,982  659,985 
Terraform Power, Inc.  72,111  1,118,442 
    2,262,146 
Water Utilities - 0.0%     
Middlesex Water Co.  6,870  431,505 
TOTAL UTILITIES    16,461,645 
TOTAL COMMON STOCKS     
(Cost $1,158,953,338)    1,832,153,679 
  Principal Amount  Value 
U.S. Treasury Obligations - 0.6%     
U.S. Treasury Bills, yield at date of purchase 1.7% to 1.82% 12/19/19 to 3/19/20 (d)     
(Cost $14,952,638)  15,000,000  14,959,966 
  Shares  Value 
Money Market Funds - 18.7%     
Fidelity Cash Central Fund 1.61% (e)  353,967,697  $354,038,491 
Fidelity Securities Lending Cash Central Fund 1.61% (e)(f)  57,424,736  57,430,478 
TOTAL MONEY MARKET FUNDS     
(Cost $411,465,901)    411,468,969 
TOTAL INVESTMENT IN SECURITIES - 102.5%     
(Cost $1,585,371,877)    2,258,582,614 
NET OTHER ASSETS (LIABILITIES) - (2.5)%    (56,112,547) 
NET ASSETS - 100%    $2,202,470,067 

Futures Contracts           
  Number of contracts  Expiration Date  Notional Amount  Value  Unrealized Appreciation/(Depreciation) 
Purchased           
Equity Index Contracts           
CME E-mini NASDAQ 100 Index Contracts (United States)  2,200  Dec. 2019  $370,370,000  $21,476,584  $21,476,584 

The notional amount of futures purchased as a percentage of Net Assets is 16.8%

For the period, the average monthly notional amount at value for futures contracts in the aggregate was $298,653,663.

Legend

 (a) Security or a portion of the security is on loan at period end.

 (b) Non-income producing

 (c) Level 3 security

 (d) Security or a portion of the security was pledged to cover margin requirements for futures contracts. At period end, the value of securities pledged amounted to $14,959,966.

 (e) Affiliated fund that is generally available only to investment companies and other accounts managed by Fidelity Investments. The rate quoted is the annualized seven-day yield of the fund at period end. A complete unaudited listing of the fund's holdings as of its most recent quarter end is available upon request. In addition, each Fidelity Central Fund's financial statements, which are not covered by the Fund's Report of Independent Registered Public Accounting Firm, are available on the SEC's website or upon request.

 (f) Investment made with cash collateral received from securities on loan.

Affiliated Central Funds

Information regarding fiscal year to date income earned by the Fund from investments in Fidelity Central Funds is as follows:

Fund  Income earned 
Fidelity Cash Central Fund  $6,266,911 
Fidelity Securities Lending Cash Central Fund  1,437,099 
Total  $7,704,010 

Amounts in the income column in the above table include any capital gain distributions from underlying funds, which are presented in the corresponding line-item in the Statement of Operations, if applicable. Amount for Fidelity Securities Lending Cash Central Fund represents the income earned on investing cash collateral, less rebates paid to borrowers and any lending agent fees associated with the loan, plus any premium payments received for lending certain types of securities.

Investment Valuation

The following is a summary of the inputs used, as of November 30, 2019, involving the Fund's assets and liabilities carried at fair value. The inputs or methodology used for valuing securities may not be an indication of the risk associated with investing in those securities. For more information on valuation inputs, and their aggregation into the levels used below, please refer to the Investment Valuation section in the accompanying Notes to Financial Statements.

  Valuation Inputs at Reporting Date: 
Description  Total  Level 1  Level 2  Level 3 
Investments in Securities:         
Equities:         
Communication Services  $317,892,055  $317,892,055  $--  $-- 
Consumer Discretionary  238,814,237  238,814,237  --  -- 
Consumer Staples  81,218,497  81,218,497  --  -- 
Energy  4,205,543  4,205,543  --  -- 
Financials  122,964,721  122,964,721  --  -- 
Health Care  192,101,672  192,055,805  --  45,867 
Industrials  84,898,641  84,898,641  --  -- 
Information Technology  742,763,166  742,763,166  --  -- 
Materials  6,076,841  6,073,424  --  3,417 
Real Estate  24,756,661  24,756,661  --  -- 
Utilities  16,461,645  16,461,645  --  -- 
U.S. Government and Government Agency Obligations  14,959,966  --  14,959,966  -- 
Money Market Funds  411,468,969  411,468,969  --  -- 
Total Investments in Securities:  $2,258,582,614  $2,243,573,364  $14,959,966  $49,284 
Derivative Instruments:         
Assets         
Futures Contracts  $21,476,584  $21,476,584  $--  $-- 
Total Assets  $21,476,584  $21,476,584  $--  $-- 
Total Derivative Instruments:  $21,476,584  $21,476,584  $--  $-- 

Value of Derivative Instruments

The following table is a summary of the Fund's value of derivative instruments by primary risk exposure as of November 30, 2019. For additional information on derivative instruments, please refer to the Derivative Instruments section in the accompanying Notes to Financial Statements.

Primary Risk Exposure / Derivative Type  Value 
  Asset  Liability 
Equity Risk     
Futures Contracts(a)  $21,476,584  $0 
Total Equity Risk  21,476,584 
Total Value of Derivatives  $21,476,584  $0 

 (a) Reflects gross cumulative appreciation (depreciation) on futures contracts as presented in the Schedule of Investments. In the Statement of Assets and Liabilities, the period end daily variation margin is included in receivable or payable for daily variation margin on futures contracts, and the net cumulative appreciation (depreciation) is included in Total accumulated earnings (loss).

See accompanying notes which are an integral part of the financial statements.


Financial Statements

Statement of Assets and Liabilities

    November 30, 2019 
Assets     
Investment in securities, at value (including securities loaned of $55,645,164) — See accompanying schedule:
Unaffiliated issuers (cost $1,173,905,976) 
$1,847,113,645   
Fidelity Central Funds (cost $411,465,901)  411,468,969   
Total Investment in Securities (cost $1,585,371,877)    $2,258,582,614 
Segregated cash with brokers for derivative instruments    1,025,123 
Foreign currency held at value (cost $5,242)    5,001 
Receivable for investments sold    3,590 
Dividends receivable    1,782,204 
Distributions receivable from Fidelity Central Funds    539,681 
Receivable for daily variation margin on futures contracts    730,889 
Prepaid expenses    14,283 
Receivable from investment adviser for expense reductions    111,708 
Other receivables    8,970 
Total assets    2,262,804,063 
Liabilities     
Payable to custodian bank  $2,372,755   
Accrued management fee  429,640   
Other affiliated payables  46,640   
Other payables and accrued expenses  58,642   
Collateral on securities loaned  57,426,319   
Total liabilities    60,333,996 
Net Assets    $2,202,470,067 
Net Assets consist of:     
Paid in capital    $1,505,664,550 
Total accumulated earnings (loss)    696,805,517 
Net Assets    $2,202,470,067 
Net Asset Value, offering price and redemption price per share ($2,202,470,067 ÷ 6,460,000 shares)    $340.94 

See accompanying notes which are an integral part of the financial statements.


Statement of Operations

    Year ended November 30, 2019 
Investment Income     
Dividends    $19,092,938 
Interest    352,980 
Income from Fidelity Central Funds (including $1,437,099 from security lending)    7,704,010 
Total income    27,149,928 
Expenses     
Management fee  $4,764,984   
Transfer agent and custody fees  30,907   
Accounting and security lending fees  504,871   
Independent trustees' fees and expenses  11,280   
Audit  67,484   
Legal  29,584   
Miscellaneous  18,882   
Total expenses before reductions  5,427,992   
Expense reductions  (1,242,844)   
Total expenses after reductions    4,185,148 
Net investment income (loss)    22,964,780 
Realized and Unrealized Gain (Loss)     
Net realized gain (loss) on:     
Investment securities:     
Unaffiliated issuers  (8,142,949)   
Redemptions in-kind  86,836,878   
Fidelity Central Funds  (1,366)   
Foreign currency transactions  10,799   
Futures contracts  12,168,291   
Total net realized gain (loss)    90,871,653 
Change in net unrealized appreciation (depreciation) on:     
Investment securities:     
Unaffiliated issuers  205,317,430   
Fidelity Central Funds  1,826   
Assets and liabilities in foreign currencies  (144)   
Futures contracts  41,289,295   
Total change in net unrealized appreciation (depreciation)    246,608,407 
Net gain (loss)    337,480,060 
Net increase (decrease) in net assets resulting from operations    $360,444,840 

See accompanying notes which are an integral part of the financial statements.


Statement of Changes in Net Assets

  Year ended November 30, 2019  Year ended November 30, 2018 
Increase (Decrease) in Net Assets     
Operations     
Net investment income (loss)  $22,964,780  $16,915,802 
Net realized gain (loss)  90,871,653  92,537,507 
Change in net unrealized appreciation (depreciation)  246,608,407  (4,534,483) 
Net increase (decrease) in net assets resulting from operations  360,444,840  104,918,826 
Distributions to shareholders  (22,429,700)  (16,311,200) 
Share transactions     
Proceeds from sales of shares  216,266,412  447,694,234 
Cost of shares redeemed  (200,133,424)  (167,424,839) 
Net increase (decrease) in net assets resulting from share transactions  16,132,988  280,269,395 
Total increase (decrease) in net assets  354,148,128  368,877,021 
Net Assets     
Beginning of period  1,848,321,939  1,479,444,918 
End of period  $2,202,470,067  $1,848,321,939 
Other Information     
Shares     
Sold  730,000  1,550,000 
Redeemed  (690,000)  (600,000) 
Net increase (decrease)  40,000  950,000 

See accompanying notes which are an integral part of the financial statements.


Fidelity Nasdaq Composite Index Tracking Stock

           
Years ended November 30,  2019  2018  2017  2016  2015 
Selected Per–Share Data           
Net asset value, beginning of period  $287.90  $270.47  $209.73  $201.07  $188.45 
Income from Investment Operations           
Net investment income (loss)A  3.53  2.76  2.40  2.43  2.14 
Net realized and unrealized gain (loss)  52.98  17.36  60.58  8.56  12.44 
Total from investment operations  56.51  20.12  62.98  10.99  14.58 
Distributions from net investment income  (3.47)  (2.69)  (2.24)  (2.33)  (1.96) 
Total distributions  (3.47)  (2.69)  (2.24)  (2.33)  (1.96) 
Net asset value, end of period  $340.94  $287.90  $270.47  $209.73  $201.07 
Total ReturnB  19.83%  7.42%  30.21%  5.56%  7.79% 
Ratios to Average Net AssetsC,D           
Expenses before reductions  .27%  .27%  .31%  .32%  .42% 
Expenses net of fee waivers, if any  .21%  .21%  .21%  .21%  .21% 
Expenses net of all reductions  .21%  .21%  .21%  .21%  .21% 
Net investment income (loss)  1.15%  .95%  .99%  1.25%  1.11% 
Supplemental Data           
Net assets, end of period (000 omitted)  $2,202,470  $1,848,322  $1,479,445  $755,017  $663,523 
Portfolio turnover rateE,F  6%  10%  12%  6%  9% 

 A Calculated based on average shares outstanding during the period.

 B Total returns would have been lower if certain expenses had not been reduced during the applicable periods shown.

 C Fees and expenses of any underlying Fidelity Central Funds are not included in the Fund's expense ratio. The Fund indirectly bears its proportionate share of the expenses of any underlying Fidelity Central Funds.

 D Expense ratios reflect operating expenses of the Fund. Expenses before reductions do not reflect amounts reimbursed by the investment adviser or reductions from expense offset arrangements and do not represent the amount paid by the Fund during periods when reimbursements or reductions occur. Expenses net of fee waivers reflect expenses after reimbursement by the investment adviser but prior to reductions from expense offset arrangements. Expenses net of all reductions represent the net expenses paid by the Fund.

 E Amount does not include the portfolio activity of any underlying Fidelity Central Funds.

 F Portfolio turnover rate excludes securities received or delivered in-kind.

See accompanying notes which are an integral part of the financial statements.


Notes to Financial Statements

For the period ended November 30, 2019

1. Organization.

Fidelity Nasdaq Composite Index Tracking Stock (the Fund) is an exchange-traded fund of Fidelity Commonwealth Trust (the Trust) and is authorized to issue an unlimited number of shares. The Trust is registered under the Investment Company Act of 1940, as amended (the 1940 Act), as an open-end management investment company organized as a Massachusetts business trust.

2. Investments in Fidelity Central Funds.

The Fund invests in Fidelity Central Funds, which are open-end investment companies generally available only to other investment companies and accounts managed by the investment adviser and its affiliates. The Fund's Schedule of Investments lists each of the Fidelity Central Funds held as of period end, if any, as an investment of the Fund, but does not include the underlying holdings of each Fidelity Central Fund. As an Investing Fund, the Fund indirectly bears its proportionate share of the expenses of the underlying Fidelity Central Funds.

The Money Market Central Funds seek preservation of capital and current income and are managed by Fidelity Investments Money Management, Inc. (FIMM), an affiliate of the investment adviser. Annualized expenses of the Money Market Central Funds as of their most recent shareholder report date ranged from less than .005% to .01%.

A complete unaudited list of holdings for each Fidelity Central Fund is available upon request or at the Securities and Exchange Commission (the SEC) website at www.sec.gov. In addition, the financial statements of the Fidelity Central Funds, which are not covered by the Fund's Report of Independent Registered Public Accounting Firm, are available on the SEC website or upon request.

3. Significant Accounting Policies.

The Fund is an investment company and applies the accounting and reporting guidance of the Financial Accounting Standards Board (FASB) Accounting Standards Codification Topic 946 Financial Services – Investments Companies. The financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (GAAP), which require management to make certain estimates and assumptions at the date of the financial statements. Actual results could differ from those estimates. Subsequent events, if any, through the date that the financial statements were issued have been evaluated in the preparation of the financial statements. The following summarizes the significant accounting policies of the Fund:

Investment Valuation. Investments are valued as of 4:00 p.m. Eastern time on the last calendar day of the period. The Board of Trustees (the Board) has delegated the day to day responsibility for the valuation of the Fund's investments to the Fair Value Committee (the Committee) established by the Fund's investment adviser. In accordance with valuation policies and procedures approved by the Board, the Fund attempts to obtain prices from one or more third party pricing vendors or brokers to value its investments. When current market prices, quotations or currency exchange rates are not readily available or reliable, investments will be fair valued in good faith by the Committee, in accordance with procedures adopted by the Board. Factors used in determining fair value vary by investment type and may include market or investment specific events, changes in interest rates and credit quality. The frequency with which these procedures are used cannot be predicted and they may be utilized to a significant extent. The Committee oversees the Fund's valuation policies and procedures and reports to the Board on the Committee's activities and fair value determinations. The Board monitors the appropriateness of the procedures used in valuing the Fund's investments and ratifies the fair value determinations of the Committee.

The Fund categorizes the inputs to valuation techniques used to value its investments into a disclosure hierarchy consisting of three levels as shown below:

  • Level 1 – quoted prices in active markets for identical investments
  • Level 2 – other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, etc.)
  • Level 3 – unobservable inputs (including the Fund's own assumptions based on the best information available)

Valuation techniques used to value the Fund's investments by major category are as follows:

Equity securities, including restricted securities, for which market quotations are readily available, are valued at the last reported sale price or official closing price as reported by a third party pricing vendor on the primary market or exchange on which they are traded and are categorized as Level 1 in the hierarchy. In the event there were no sales during the day or closing prices are not available, securities are valued at the last quoted bid price or may be valued using the last available price and are generally categorized as Level 2 in the hierarchy. For foreign equity securities, when market or security specific events arise, comparisons to the valuation of American Depositary Receipts (ADRs), futures contracts, Exchange-Traded Funds (ETFs) and certain indexes as well as quoted prices for similar securities may be used and would be categorized as Level 2 in the hierarchy. For equity securities, including restricted securities, where observable inputs are limited, assumptions about market activity and risk are used and these securities may be categorized as Level 3 in the hierarchy.

Debt securities, including restricted securities, are valued based on evaluated prices received from third party pricing vendors or from brokers who make markets in such securities. U.S. government and government agency obligations are valued by pricing vendors who utilize matrix pricing which considers yield or price of bonds of comparable quality, coupon, maturity and type or by broker-supplied prices. When independent prices are unavailable or unreliable, debt securities may be valued utilizing pricing methodologies which consider similar factors that would be used by third party pricing vendors. Debt securities are generally categorized as Level 2 in the hierarchy but may be Level 3 depending on the circumstances.

Futures contracts are valued at the settlement price established each day by the board of trade or exchange on which they are traded and are categorized as Level 1 in the hierarchy. Investments in open-end mutual funds, including the Fidelity Central Funds, are valued at their closing net asset value (NAV) each business day and are categorized as Level 1 in the hierarchy.

Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy. The aggregate value of investments by input level as of November 30, 2019 is included at the end of the Fund's Schedule of Investments.

Foreign Currency. The Fund may use foreign currency contracts to facilitate transactions in foreign-denominated securities. Gains and losses from these transactions may arise from changes in the value of the foreign currency or if the counterparties do not perform under the contracts' terms.

Foreign-denominated assets, including investment securities, and liabilities are translated into U.S. dollars at the exchange rates at period end. Purchases and sales of investment securities, income and dividends received and expenses denominated in foreign currencies are translated into U.S. dollars at the exchange rate in effect on the transaction date.

The effects of exchange rate fluctuations on investments are included with the net realized and unrealized gain (loss) on investment securities. Other foreign currency transactions resulting in realized and unrealized gain (loss) are disclosed separately.

Investment Transactions and Income. For financial reporting purposes, the Fund's investment holdings and NAV include trades executed through the end of the last business day of the period. The NAV per share for processing shareholder transactions is calculated as of the close of business of the New York Stock Exchange (NYSE), normally 4:00 p.m. Eastern time and includes trades executed through the end of the prior business day. Gains and losses on securities sold are determined on the basis of identified cost and include proceeds received from litigation. Dividend income is recorded on the ex-dividend date, except for certain dividends from foreign securities where the ex-dividend date may have passed, which are recorded as soon as the Fund is informed of the ex-dividend date. Non-cash dividends included in dividend income, if any, are recorded at the fair market value of the securities received. Income and capital gain distributions from Fidelity Central Funds, if any, are recorded on the ex-dividend date. Certain distributions received by the Fund represent a return of capital or capital gain. The Fund determines the components of these distributions subsequent to the ex-dividend date, based upon receipt of tax filings or other correspondence relating to the underlying investment. These distributions are recorded as a reduction of cost of investments and/or as a realized gain. Interest income is accrued as earned and includes coupon interest and amortization of premium and accretion of discount on debt securities as applicable. Investment income is recorded net of foreign taxes withheld where recovery of such taxes is uncertain.

Expenses. Expenses directly attributable to a fund are charged to that fund. Expenses attributable to more than one fund are allocated among the respective funds on the basis of relative net assets or other appropriate methods. Expense estimates are accrued in the period to which they relate and adjustments are made when actual amounts are known.

Income Tax Information and Distributions to Shareholders. Each year, the Fund intends to qualify as a regulated investment company under Subchapter M of the Internal Revenue Code, including distributing substantially all of its taxable income and realized gains. As a result, no provision for U.S. Federal income taxes is required. As of November 30, 2019, the Fund did not have any unrecognized tax benefits in the financial statements; nor is the Fund aware of any tax positions for which it is reasonably possible that the total amounts of unrecognized tax benefits will significantly change in the next twelve months. The Fund files a U.S. federal tax return, in addition to state and local tax returns as required. The Fund's federal income tax returns are subject to examination by the Internal Revenue Service (IRS) for a period of three fiscal years after they are filed. State and local tax returns may be subject to examination for an additional fiscal year depending on the jurisdiction. Realized gain or loss resulting from in-kind redemptions is not taxable to the Fund and is not distributed to shareholders of the Fund. Foreign taxes are provided for based on the Fund's understanding of the tax rules and rates that exist in the foreign markets in which it invests.

Distributions are recorded on the ex-dividend date. Income and capital gain distributions are determined in accordance with income tax regulations, which may differ from GAAP.

Capital accounts within the financial statements are adjusted for permanent book-tax differences. These adjustments have no impact on net assets or the results of operations. Capital accounts are not adjusted for temporary book-tax differences which will reverse in a subsequent period.

Book-tax differences are primarily due to futures contracts, foreign currency transactions, passive foreign investment companies (PFIC), market discount, redemptions in kind, partnerships, capital loss carryforwards and losses deferred due to wash sales.

As of period end, the cost and unrealized appreciation (depreciation) in securities, and derivatives if applicable, for federal income tax purposes were as follows:

Gross unrealized appreciation  $716,636,760 
Gross unrealized depreciation  (43,860,445) 
Net unrealized appreciation (depreciation)  $672,776,315 
Tax Cost  $1,585,806,299 

The tax-based components of distributable earnings as of period end were as follows:

Undistributed ordinary income  $5,356,211 
Undistributed long-term capital gain  $18,885,674 
Net unrealized appreciation (depreciation) on securities and other investments  $672,563,632 

The tax character of distributions paid was as follows:

  November 30, 2019  November 30, 2018 
Ordinary Income  $22,429,700  $ 16,311,200 

4. Derivative Instruments.

Risk Exposures and the Use of Derivative Instruments. The Fund's investment objective allows the Fund to enter into various types of derivative contracts, including futures contracts. Derivatives are investments whose value is primarily derived from underlying assets, indices or reference rates and may be transacted on an exchange or over-the-counter (OTC). Derivatives may involve a future commitment to buy or sell a specified asset based on specified terms, to exchange future cash flows at periodic intervals based on a notional principal amount, or for one party to make one or more payments upon the occurrence of specified events in exchange for periodic payments from the other party.

The Fund used derivatives to increase returns and to manage exposure to certain risks as defined below. The success of any strategy involving derivatives depends on analysis of numerous economic factors, and if the strategies for investment do not work as intended, the Fund may not achieve its objectives.

The Fund's use of derivatives increased or decreased its exposure to the following risk:

Equity Risk  Equity risk relates to the fluctuations in the value of financial instruments as a result of changes in market prices (other than those arising from interest rate risk or foreign exchange risk), whether caused by factors specific to an individual investment, its issuer, or all factors affecting all instruments traded in a market or market segment.
 

The Fund is also exposed to additional risks from investing in derivatives, such as liquidity risk and counterparty credit risk. Liquidity risk is the risk that the Fund will be unable to close out the derivative in the open market in a timely manner. Counterparty credit risk is the risk that the counterparty will not be able to fulfill its obligation to the Fund. Counterparty credit risk related to exchange-traded futures contracts may be mitigated by the protection provided by the exchange on which they trade.

Investing in derivatives may involve greater risks than investing in the underlying assets directly and, to varying degrees, may involve risk of loss in excess of any initial investment and collateral received and amounts recognized in the Statement of Assets and Liabilities. In addition, there may be the risk that the change in value of the derivative contract does not correspond to the change in value of the underlying instrument.

Futures Contracts. A futures contract is an agreement between two parties to buy or sell a specified underlying instrument for a fixed price at a specified future date. The Fund used futures contracts to manage its exposure to the stock market.

Upon entering into a futures contract, a fund is required to deposit either cash or securities (initial margin) with a clearing broker in an amount equal to a certain percentage of the face value of the contract. Futures contracts are marked-to-market daily and subsequent daily payments (variation margin) are made or received by a fund depending on the daily fluctuations in the value of the futures contracts and are recorded as unrealized appreciation or (depreciation). This receivable and/or payable, if any, is included in daily variation margin on futures contracts in the Statement of Assets and Liabilities. Realized gain or (loss) is recorded upon the expiration or closing of a futures contract. The net realized gain (loss) and change in net unrealized appreciation (depreciation) on futures contracts during the period is presented in the Statement of Operations.

Any open futures contracts at period end are presented in the Schedule of Investments under the caption "Futures Contracts". The notional amount at value reflects each contract's exposure to the underlying instrument or index at period end. Securities deposited to meet initial margin requirements are identified in the Schedule of Investments. Cash deposited to meet initial margin requirements is presented as segregated cash with brokers for derivative instruments in the Statement of Assets and Liabilities.

5. Purchases and Sales of Investments.

Purchases and sales of securities, other than short-term securities and in-kind transactions, aggregated $102,493,252 and $140,388,032, respectively.

Securities received and delivered in-kind through subscriptions and redemptions totaled $172,470,290 and $159,510,871, respectively.

6. Fees and Other Transactions with Affiliates.

Management Fee. FMR Co., Inc. (the investment adviser) and its affiliates provide the Fund with investment management related services for which the Fund pays a monthly management fee that is based on an annual rate of .24% of the Fund's average net assets. During January 2019, the Board approved to change the investment adviser from Fidelity Management & Research Company to FMR Co., Inc. effective February 1, 2019. There was no change to the management fee.

During November 2019, the Board approved to change the management fee structure for the Fund from a flat fee to an all-inclusive fee effective December 1, 2019. The Fund will pay a monthly management fee that is based on an annual rate of .21% of the Fund's average net assets. Under the management contract, the investment adviser will pay all other operating expenses, except the compensation of the independent Trustees and certain miscellaneous expenses such as proxy and shareholder meeting expenses.

Sub-Adviser. Geode Capital Management, LLC (Geode), serves as sub-adviser for the Fund. Geode provides discretionary investment advisory services to the Fund and is paid by the investment adviser for providing these services.

Accounting and Security Lending Fees. Fidelity Service Company, Inc. (FSC), an affiliate of the investment adviser, maintains the Fund's accounting records. The accounting fee is based on the level of average net assets for each month. Prior to April 1, 2019, FSC had a separate agreement with the Fund for administration of the security lending program, based on the number and duration of lending transactions. For the period, the total fees paid for accounting and administration of securities lending were equivalent to an annual rate of .03%.

Interfund Trades. The Fund may purchase from or sell securities to other Fidelity Funds under procedures adopted by the Board. The procedures have been designed to ensure these interfund trades are executed in accordance with Rule 17a-7 of the 1940 Act. Interfund trades are included within the respective purchases and sales amounts shown in the Purchases and Sales of Investments note.

7. Security Lending.

The Fund lends portfolio securities from time to time in order to earn additional income. For equity securities, lending agents are used, including National Financial Services (NFS), an affiliate of the Fund. Pursuant to a securities lending agreement, NFS will receive a fee, which is capped at 9.9% of daily lending revenue, for its services as lending agent. The Fund may lend securities to certain qualified borrowers, including NFS. On the settlement date of the loan, the Fund receives collateral (in the form of U.S. Treasury obligations, letters of credit and/or cash) against the loaned securities and maintains collateral in an amount not less than 100% of the market value of the loaned securities during the period of the loan. The market value of the loaned securities is determined at the close of business of the Fund and any additional required collateral is delivered to the Fund on the next business day. The Fund or borrower may terminate the loan at any time, and if the borrower defaults on its obligation to return the securities loaned because of insolvency or other reasons, the Fund may apply collateral received from the borrower against the obligation. The Fund may experience delays and costs in recovering the securities loaned. Any cash collateral received is invested in the Fidelity Securities Lending Cash Central Fund. The value of loaned securities and cash collateral at period end are disclosed on the Fund's Statement of Assets and Liabilities. The value of securities loaned to NFS, as affiliated borrower, at period end was $798,488. Total fees paid by the Fund to NFS, as lending agent, amounted to $67,833. Security lending income represents the income earned on investing cash collateral, less rebates paid to borrowers and any lending agent fees associated with the loan, plus any premium payments received for lending certain types of securities. Security lending income is presented in the Statement of Operations as a component of income from Fidelity Central Funds, and includes $65,102 from securities loaned to NFS, as affiliated borrower.

8. Expense Reductions.

The investment adviser contractually agreed to reimburse expenses of the Fund to the extent annual operating expenses exceeded .21% of average net assets. Some expenses, for example the compensation of the independent Trustees, and certain miscellaneous expenses such as proxy and shareholder meeting expenses, are excluded from this reimbursement. During the period this reimbursement reduced the Fund's expenses by $1,241,474.

During November 2019, the Board approved to discontinue the expense limitation effective December 1, 2019.

In addition, through arrangements with the Fund's custodian, credits realized as a result of certain uninvested cash balances were used to reduce the Fund's expenses by $1,370.

9. Share Transactions.

The Fund issues and redeems shares at NAV only with certain authorized participants in large increments known as Creation Units. Purchases of Creation Units are made by tendering a basket of designated stocks to the Fund and redemption proceeds are paid with a basket of securities from the Fund's portfolio with a balancing cash component to equate the market value of the basket of securities delivered or redeemed to the NAV per Creation Unit on the transaction date. Cash may be substituted equivalent to the value of certain securities generally when they are not available in sufficient quantity for delivery. The Fund's shares are available in smaller increments to investors in the secondary market at market prices and may be subject to commissions. Authorized participants pay a transaction fee to the shareholder servicing agent when purchasing and redeeming Creation Units of the Fund. The transaction fee is used to defray the costs associated with the issuance and redemption of Creation Units.

10. Other.

The Fund's organizational documents provide former and current trustees and officers with a limited indemnification against liabilities arising in connection with the performance of their duties to the Fund. In the normal course of business, the Fund may also enter into contracts that provide general indemnifications. The Fund's maximum exposure under these arrangements is unknown as this would be dependent on future claims that may be made against the Fund. The risk of material loss from such claims is considered remote.

Effective January 1, 2020, following any required regulatory notices and approvals:

Investment advisers Fidelity Investments Money Management, Inc., FMR Co., Inc., and Fidelity SelectCo, LLC, merged with and into Fidelity Management & Research Company. In connection with the merger transactions, the resulting, merged investment adviser was then redomiciled from Massachusetts to Delaware, changed its corporate structure from a corporation to a limited liability company, and changed its name to "Fidelity Management & Research Company LLC".

Report of Independent Registered Public Accounting Firm

To the Board of Trustees of Fidelity Commonwealth Trust and Shareholders of Fidelity Nasdaq Composite Index Tracking Stock:

Opinion on the Financial Statements

We have audited the accompanying statement of assets and liabilities, including the schedule of investments, of Fidelity Nasdaq Composite Index Tracking Stock (one of the funds constituting Fidelity Commonwealth Trust, referred to hereafter as the “Fund”) as of November 30, 2019, the related statement of operations for the year ended November 30, 2019, the statement of changes in net assets for each of the two years in the period ended November 30, 2019, including the related notes, and the financial highlights for each of the five years in the period ended November 30, 2019 (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Fund as of November 30, 2019, the results of its operations for the year then ended, the changes in its net assets for each of the two years in the period ended November 30, 2019 and the financial highlights for each of the five years in the period ended November 30, 2019 in conformity with accounting principles generally accepted in the United States of America.

Basis for Opinion

These financial statements are the responsibility of the Fund’s management. Our responsibility is to express an opinion on the Fund’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Fund in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits of these financial statements in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud.

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. Our procedures included confirmation of securities owned as of November 30, 2019 by correspondence with the custodian. We believe that our audits provide a reasonable basis for our opinion.

PricewaterhouseCoopers LLP

Boston, Massachusetts

January 14, 2020



We have served as the auditor of one or more investment companies in the Fidelity group of funds since 1932.

Trustees and Officers

The Trustees, Members of the Advisory Board (if any), and officers of the trust and fund, as applicable, are listed below. The Board of Trustees governs the fund and is responsible for protecting the interests of shareholders. The Trustees are experienced executives who meet periodically throughout the year to oversee the fund's activities, review contractual arrangements with companies that provide services to the fund, oversee management of the risks associated with such activities and contractual arrangements, and review the fund's performance.  Except for Michael E. Wiley, each of the Trustees oversees 302 funds. Mr. Wiley oversees 199 funds. 

The Trustees hold office without limit in time except that (a) any Trustee may resign; (b) any Trustee may be removed by written instrument, signed by at least two-thirds of the number of Trustees prior to such removal; (c) any Trustee who requests to be retired or who has become incapacitated by illness or injury may be retired by written instrument signed by a majority of the other Trustees; and (d) any Trustee may be removed at any special meeting of shareholders by a two-thirds vote of the outstanding voting securities of the trust.  Each Trustee who is not an interested person (as defined in the 1940 Act) of the trust and the fund is referred to herein as an Independent Trustee.  Each Independent Trustee shall retire not later than the last day of the calendar year in which his or her 75th birthday occurs.  The Independent Trustees may waive this mandatory retirement age policy with respect to individual Trustees.  Officers and Advisory Board Members hold office without limit in time, except that any officer or Advisory Board Member may resign or may be removed by a vote of a majority of the Trustees at any regular meeting or any special meeting of the Trustees. Except as indicated, each individual has held the office shown or other offices in the same company for the past five years. 

The fund’s Statement of Additional Information (SAI) includes more information about the Trustees. To request a free copy, call Fidelity at 1-800-FIDELITY.

Experience, Skills, Attributes, and Qualifications of the Trustees. The Governance and Nominating Committee has adopted a statement of policy that describes the experience, qualifications, attributes, and skills that are necessary and desirable for potential Independent Trustee candidates (Statement of Policy). The Board believes that each Trustee satisfied at the time he or she was initially elected or appointed a Trustee, and continues to satisfy, the standards contemplated by the Statement of Policy. The Governance and Nominating Committee also engages professional search firms to help identify potential Independent Trustee candidates who have the experience, qualifications, attributes, and skills consistent with the Statement of Policy. From time to time, additional criteria based on the composition and skills of the current Independent Trustees, as well as experience or skills that may be appropriate in light of future changes to board composition, business conditions, and regulatory or other developments, have also been considered by the professional search firms and the Governance and Nominating Committee. In addition, the Board takes into account the Trustees' commitment and participation in Board and committee meetings, as well as their leadership of standing and ad hoc committees throughout their tenure.

In determining that a particular Trustee was and continues to be qualified to serve as a Trustee, the Board has considered a variety of criteria, none of which, in isolation, was controlling. The Board believes that, collectively, the Trustees have balanced and diverse experience, qualifications, attributes, and skills, which allow the Board to operate effectively in governing the fund and protecting the interests of shareholders. Information about the specific experience, skills, attributes, and qualifications of each Trustee, which in each case led to the Board's conclusion that the Trustee should serve (or continue to serve) as a trustee of the fund, is provided below.

Board Structure and Oversight Function. James C. Curvey is an interested person and currently serves as Chairman. The Trustees have determined that an interested Chairman is appropriate and benefits shareholders because an interested Chairman has a personal and professional stake in the quality and continuity of services provided to the fund. Independent Trustees exercise their informed business judgment to appoint an individual of their choosing to serve as Chairman, regardless of whether the Trustee happens to be independent or a member of management. The Independent Trustees have determined that they can act independently and effectively without having an Independent Trustee serve as Chairman and that a key structural component for assuring that they are in a position to do so is for the Independent Trustees to constitute a substantial majority for the Board. The Independent Trustees also regularly meet in executive session. Ned C. Lautenbach serves as Chairman of the Independent Trustees and as such (i) acts as a liaison between the Independent Trustees and management with respect to matters important to the Independent Trustees and (ii) with management prepares agendas for Board meetings.

Fidelity® funds are overseen by different Boards of Trustees. The fund's Board oversees Fidelity's high income and certain equity funds, and other Boards oversee Fidelity's investment-grade bond, money market, asset allocation, and other equity funds. The asset allocation funds may invest in Fidelity® funds overseen by the fund's Board. The use of separate Boards, each with its own committee structure, allows the Trustees of each group of Fidelity® funds to focus on the unique issues of the funds they oversee, including common research, investment, and operational issues. On occasion, the separate Boards establish joint committees to address issues of overlapping consequences for the Fidelity® funds overseen by each Board.

The Trustees operate using a system of committees to facilitate the timely and efficient consideration of all matters of importance to the Trustees, the fund, and fund shareholders and to facilitate compliance with legal and regulatory requirements and oversight of the fund's activities and associated risks.  The Board, acting through its committees, has charged FMR and its affiliates with (i) identifying events or circumstances the occurrence of which could have demonstrably adverse effects on the fund's business and/or reputation; (ii) implementing processes and controls to lessen the possibility that such events or circumstances occur or to mitigate the effects of such events or circumstances if they do occur; and (iii) creating and maintaining a system designed to evaluate continuously business and market conditions in order to facilitate the identification and implementation processes described in (i) and (ii) above.  Because the day-to-day operations and activities of the fund are carried out by or through FMR, its affiliates, and other service providers, the fund's exposure to risks is mitigated but not eliminated by the processes overseen by the Trustees.  While each of the Board's committees has responsibility for overseeing different aspects of the fund's activities, oversight is exercised primarily through the Operations, Audit, and Compliance Committees.  Appropriate personnel, including but not limited to the fund's Chief Compliance Officer (CCO), FMR's internal auditor, the independent accountants, the fund's Treasurer and portfolio management personnel, make periodic reports to the Board's committees, as appropriate, including an annual review of Fidelity's risk management program for the Fidelity® funds.  The responsibilities of each standing committee, including their oversight responsibilities, are described further under "Standing Committees of the Trustees." 

Interested Trustees*:

Correspondence intended for a Trustee who is an interested person may be sent to Fidelity Investments, 245 Summer Street, Boston, Massachusetts 02210.

Name, Year of Birth; Principal Occupations and Other Relevant Experience+

James C. Curvey (1935)

Year of Election or Appointment: 2018

Trustee

Chairman of the Board of Trustees

Mr. Curvey also serves as Trustee of other Fidelity® funds. Mr. Curvey is Vice Chairman (2007-present) and Director of FMR LLC (diversified financial services company). In addition, Mr. Curvey is an Overseer Emeritus for the Boston Symphony Orchestra, a Director of Artis-Naples, and a Trustee of Brewster Academy in Wolfeboro, New Hampshire. Previously, Mr. Curvey served as a Director of Fidelity Research & Analysis Co. (investment adviser firm, 2009-2018), Director of Fidelity Investments Money Management, Inc. (investment adviser firm, 2009-2014) and a Director of FMR and FMR Co., Inc. (investment adviser firms, 2007-2014).

 * Determined to be an “Interested Trustee” by virtue of, among other things, his or her affiliation with the trust or various entities under common control with FMR. 

 + The information includes the Trustee's principal occupation during the last five years and other information relating to the experience, attributes, and skills relevant to the Trustee's qualifications to serve as a Trustee, which led to the conclusion that the Trustee should serve as a Trustee for the fund. 

Independent Trustees:

Correspondence intended for an Independent Trustee may be sent to Fidelity Investments, P.O. Box 55235, Boston, Massachusetts 02205-5235.

Name, Year of Birth; Principal Occupations and Other Relevant Experience+

Dennis J. Dirks (1948)

Year of Election or Appointment: 2018

Trustee

Mr. Dirks also serves as Trustee of other Fidelity® funds. Prior to his retirement in May 2003, Mr. Dirks was Chief Operating Officer and a member of the Board of The Depository Trust & Clearing Corporation (DTCC). He also served as President, Chief Operating Officer, and Board member of The Depository Trust Company (DTC) and President and Board member of the National Securities Clearing Corporation (NSCC). In addition, Mr. Dirks served as Chief Executive Officer and Board member of the Government Securities Clearing Corporation, Chief Executive Officer and Board member of the Mortgage-Backed Securities Clearing Corporation, as a Trustee and a member of the Finance Committee of Manhattan College (2005-2008), as a Trustee and a member of the Finance Committee of AHRC of Nassau County (2006-2008), as a member of the Independent Directors Council (IDC) Governing Council (2010-2015), and as a member of the Board of Directors for The Brookville Center for Children’s Services, Inc. (2009-2017). Mr. Dirks is a member of the Finance Committee (2016-present) and Board of Directors (2017-present) and is Treasurer (2018-present) of the Asolo Repertory Theatre.

Donald F. Donahue (1950)

Year of Election or Appointment: 2017

Trustee

Mr. Donahue also serves as a Trustee of other Fidelity® funds. Mr. Donahue is President and Chief Executive Officer of Miranda Partners, LLC (risk consulting for the financial services industry, 2012-present). Previously, Mr. Donahue served as a Member of the Advisory Board of certain Fidelity® funds (2015-2018) and Chief Executive Officer (2006-2012), Chief Operating Officer (2003-2006), and Managing Director, Customer Marketing and Development (1999-2003) of The Depository Trust & Clearing Corporation (financial markets infrastructure). Mr. Donahue serves as a Member (2007-present) and Co-Chairman (2016-present) of the Board of Directors of United Way of New York, Member of the Board of Directors of NYC Leadership Academy (2012-present) and Member of the Board of Advisors of Ripple Labs, Inc. (financial services, 2015-present). He also served as Chairman (2010-2012) and Member of the Board of Directors (2012-2013) of Omgeo, LLC (financial services), Treasurer of United Way of New York (2012-2016), and Member of the Board of Directors of XBRL US (financial services non-profit, 2009-2012) and the International Securities Services Association (2009-2012).

Alan J. Lacy (1953)

Year of Election or Appointment: 2018

Trustee

Mr. Lacy also serves as Trustee of other Fidelity® funds. Mr. Lacy serves as a Director of Bristol-Myers Squibb Company (global pharmaceuticals, 2008-present). He is a Trustee of the California Chapter of The Nature Conservancy (2015-present) and a Director of the Center for Advanced Study in the Behavioral Sciences at Stanford University (2015-present). In addition, Mr. Lacy served as Senior Adviser (2007-2014) of Oak Hill Capital Partners, L.P. (private equity) and also served as Chief Executive Officer (2005) and Vice Chairman (2005-2006) of Sears Holdings Corporation (retail) and Chief Executive Officer and Chairman of the Board of Sears, Roebuck and Co. (retail, 2000-2005). Previously, Mr. Lacy served as Chairman (2014-2017) and a member (2010-2017) of the Board of Directors of Dave & Buster’s Entertainment, Inc. (restaurant and entertainment complexes), as Chairman (2008-2011) and a member (2006-2015) of the Board of Trustees of the National Parks Conservation Association, and as a member of the Board of Directors for The Hillman Companies, Inc. (hardware wholesalers, 2010-2014), Earth Fare, Inc. (retail grocery, 2010-2014), and The Western Union Company (global money transfer, 2006-2011).

Ned C. Lautenbach (1944)

Year of Election or Appointment: 2018

Trustee

Chairman of the Independent Trustees

Mr. Lautenbach also serves as Trustee of other Fidelity® funds. Mr. Lautenbach currently serves as Chair (2018-present) and Member (2013-present) of the Board of Governors, State University System of Florida and is a member of the Council on Foreign Relations (1994-present). He is also a member and has most recently served as Chairman of the Board of Directors of Artis-Naples (2012-present). Previously, Mr. Lautenbach served as a member and then Lead Director of the Board of Directors of Eaton Corporation (diversified industrial, 1997-2016). He was also a Partner and Advisory Partner at Clayton, Dubilier & Rice, LLC (private equity investment, 1998-2010), as well as a Director of Sony Corporation (2006-2007). In addition, Mr. Lautenbach also had a 30-year career with IBM (technology company) during which time he served as Senior Vice President and a member of the Corporate Executive Committee (1968-1998).

Joseph Mauriello (1944)

Year of Election or Appointment: 2018

Trustee

Mr. Mauriello also serves as Trustee of other Fidelity® funds. Prior to his retirement in January 2006, Mr. Mauriello served in numerous senior management positions including Deputy Chairman and Chief Operating Officer (2004-2005), and Vice Chairman of Financial Services (2002-2004) of KPMG LLP US (professional services, 1965-2005). Mr. Mauriello currently serves as a member of the Independent Directors Council (IDC) Governing Council (2015-present). Previously, Mr. Mauriello served as a member of the Board of Directors of XL Group plc. (global insurance and re-insurance, 2006-2018).

Cornelia M. Small (1944)

Year of Election or Appointment: 2018

Trustee

Ms. Small also serves as Trustee of other Fidelity® funds. Ms. Small is a member of the Board of Directors (2009-present) and Chair of the Investment Committee (2010-present) of the Teagle Foundation. Ms. Small also serves on the Investment Committee of the Berkshire Taconic Community Foundation (2008-present). Previously, Ms. Small served as Chairperson (2002-2008) and a member of the Investment Committee and Chairperson (2008-2012) and a member of the Board of Trustees of Smith College. In addition, Ms. Small served as Chief Investment Officer, Director of Global Equity Investments, and a member of the Board of Directors of Scudder, Stevens & Clark and Scudder Kemper Investments.

Garnett A. Smith (1947)

Year of Election or Appointment: 2017

Trustee

Mr. Smith also serves as Trustee of other Fidelity® funds. Prior to Mr. Smith's retirement, he served as Chairman and Chief Executive Officer of Inbrand Corp. (manufacturer of personal absorbent products, 1990-1997). He also served as President (1986-1990) of Inbrand Corp. Prior to his employment with Inbrand Corp., he was employed by a retail fabric chain and North Carolina National Bank. In addition, Mr. Smith served as a Member of the Advisory Board of certain Fidelity® funds (2012-2013) and as a board member of the Jackson Hole Land Trust (2009-2012).

David M. Thomas (1949)

Year of Election or Appointment: 2018

Trustee

Mr. Thomas also serves as Trustee of other Fidelity® funds. Mr. Thomas serves as Non-Executive Chairman of the Board of Directors of Fortune Brands Home and Security (home and security products, 2011-present) and as a member of the Board of Directors (2004-present) and Presiding Director (2013-present) of Interpublic Group of Companies, Inc. (marketing communication). Previously, Mr. Thomas served as Executive Chairman (2005-2006) and Chairman and Chief Executive Officer (2000-2005) of IMS Health, Inc. (pharmaceutical and healthcare information solutions), a Director of Fortune Brands, Inc. (consumer products, 2000-2011), and a member of the Board of Trustees of the University of Florida (2013-2018).

Michael E. Wiley (1950)

Year of Election or Appointment: 2017

Trustee

Mr. Wiley also serves as Trustee or Member of the Advisory Board of other Fidelity® funds. Mr. Wiley serves as a Director of High Point Resources (exploration and production, 2005-present). Previously, Mr. Wiley served as a Director of Andeavor Corporation (independent oil refiner and marketer, 2005-2018), a Director of Andeavor Logistics LP (natural resources logistics, 2015-2018), a Director of Post Oak Bank (privately-held bank, 2004-2018), a Director of Asia Pacific Exploration Consolidated (international oil and gas exploration and production, 2008-2013), a member of the Board of Trustees of the University of Tulsa (2000-2006; 2007-2010), a Senior Energy Advisor of Katzenbach Partners, LLC (consulting, 2006-2007), an Advisory Director of Riverstone Holdings (private investment), a Director of Spinnaker Exploration Company (exploration and production, 2001-2005) and Chairman, President, and CEO of Baker Hughes, Inc. (oilfield services, 2000-2004).

 + The information includes the Trustee's principal occupation during the last five years and other information relating to the experience, attributes, and skills relevant to the Trustee's qualifications to serve as a Trustee, which led to the conclusion that the Trustee should serve as a Trustee for the fund. 

Advisory Board Members and Officers:

Correspondence intended for a Member of the Advisory Board (if any) may be sent to Fidelity Investments, P.O. Box 55235, Boston, Massachusetts 02205-5235.  Correspondence intended for an officer or Peter S. Lynch may be sent to Fidelity Investments, 245 Summer Street, Boston, Massachusetts 02210.  Officers appear below in alphabetical order. 

Name, Year of Birth; Principal Occupation

Vicki L. Fuller (1957)

Year of Election or Appointment: 2018

Member of the Advisory Board

Ms. Fuller also serves as Member of the Advisory Board of other Fidelity® funds. Ms. Fuller serves as a member of the Board of Directors, Audit Committee, and Nominating and Governance Committee of The Williams Companies, Inc. (natural gas infrastructure, 2018-present). Previously, Ms. Fuller served as the Chief Investment Officer of the New York State Common Retirement Fund (2012-2018) and held a variety of positions at AllianceBernstein L.P. (global asset management, 1985-2012), including Managing Director (2006-2012) and Senior Vice President and Senior Portfolio Manager (2001-2006).

Peter S. Lynch (1944)

Year of Election or Appointment: 2018

Member of the Advisory Board

Mr. Lynch also serves as Member of the Advisory Board of other Fidelity® funds. Mr. Lynch is Vice Chairman and a Director of Fidelity Management & Research Company LLC (investment adviser firm). In addition, Mr. Lynch serves as a Trustee of Boston College and as the Chairman of the Inner-City Scholarship Fund. Previously, Mr. Lynch served as Vice Chairman and a Director of FMR Co., Inc. (investment adviser firm) and on the Special Olympics International Board of Directors (1997-2006).

Elizabeth Paige Baumann (1968)

Year of Election or Appointment: 2017

Anti-Money Laundering (AML) Officer

Ms. Baumann also serves as AML Officer of other funds. She is Chief AML Officer (2012-present) and Senior Vice President (2014-present) of FMR LLC (diversified financial services company) and is an employee of Fidelity Investments. Previously, Ms. Baumann served as AML Officer of the funds (2012-2016), and Vice President (2007-2014) and Deputy Anti-Money Laundering Officer (2007-2012) of FMR LLC.

Craig S. Brown (1977)

Year of Election or Appointment: 2019

Assistant Treasurer

Mr. Brown also serves as Assistant Treasurer of other funds. Mr. Brown is an employee of Fidelity Investments (2013-present).

John J. Burke III (1964)

Year of Election or Appointment: 2018

Chief Financial Officer

Mr. Burke also serves as Chief Financial Officer of other funds. Mr. Burke serves as Head of Investment Operations for Fidelity Fund and Investment Operations (2018-present) and is an employee of Fidelity Investments (1998-present). Previously Mr. Burke served as head of Asset Management Investment Operations (2012-2018).

William C. Coffey (1969)

Year of Election or Appointment: 2019

Assistant Secretary

Mr. Coffey also serves as Assistant Secretary of other funds. He is Senior Vice President and Deputy General Counsel of FMR LLC (diversified financial services company, 2010-present), and is an employee of Fidelity Investments. Previously, Mr. Coffey served as Secretary and CLO of certain funds (2018-2019); CLO, Secretary, and Senior Vice President of Fidelity Management & Research Company and FMR Co., Inc. (investment adviser firms, 2018-2019); Secretary of Fidelity SelectCo, LLC and Fidelity Investments Money Management, Inc. (investment adviser firms, 2018-2019); CLO of Fidelity Management & Research (Hong Kong) Limited, FMR Investment Management (UK) Limited, and Fidelity Management & Research (Japan) Limited (investment adviser firms, 2018-2019); and Assistant Secretary of certain funds (2009-2018).

Timothy M. Cohen (1969)

Year of Election or Appointment: 2018

Vice President

Mr. Cohen also serves as Vice President of other funds. Mr. Cohen serves as Co-Head of Equity (2018-present), a Director of Fidelity Management & Research (Japan) Limited (investment adviser firm, 2016-present), and is an employee of Fidelity Investments. Previously, Mr. Cohen served as Executive Vice President of Fidelity SelectCo, LLC (2019), Head of Global Equity Research (2016-2018), Chief Investment Officer - Equity and a Director of Fidelity Management & Research (U.K.) Inc. (investment adviser firm, 2013-2015) and as a Director of Fidelity Management & Research (Hong Kong) Limited (investment adviser firm, 2017).

Jonathan Davis (1968)

Year of Election or Appointment: 2017

Assistant Treasurer

Mr. Davis also serves as Assistant Treasurer of other funds. Mr. Davis serves as Assistant Treasurer of FMR Capital, Inc. (2017-present) and is an employee of Fidelity Investments. Previously, Mr. Davis served as Vice President and Associate General Counsel of FMR LLC (diversified financial services company, 2003-2010).

Laura M. Del Prato (1964)

Year of Election or Appointment: 2018

Assistant Treasurer

Ms. Del Prato also serves as an officer of other funds. Ms. Del Prato is an employee of Fidelity Investments (2017-present). Prior to joining Fidelity Investments, Ms. Del Prato served as a Managing Director and Treasurer of the JPMorgan Mutual Funds (2014-2017). Prior to JPMorgan, Ms. Del Prato served as a partner at Cohen Fund Audit Services (accounting firm, 2012-2013) and KPMG LLP (accounting firm, 2004-2012).

Colm A. Hogan (1973)

Year of Election or Appointment: 2018

Deputy Treasurer

Mr. Hogan also serves as an officer of other funds. Mr. Hogan serves as Assistant Treasurer of FMR Capital, Inc. (2017-present) and is an employee of Fidelity Investments (2005-present). Previously, Mr. Hogan served as Assistant Treasurer of certain Fidelity® funds (2016-2018). 

Pamela R. Holding (1964)

Year of Election or Appointment: 2018

Vice President

Ms. Holding also serves as Vice President of other funds. Ms. Holding serves as Co-Head of Equity (2018-present) and is an employee of Fidelity Investments (2013-present). Previously, Ms. Holding served as Executive Vice President of Fidelity SelectCo, LLC (2019) and as Chief Investment Officer of Fidelity Institutional Asset Management (2013-2018).

Cynthia Lo Bessette (1969)

Year of Election or Appointment: 2019

Secretary and Chief Legal Officer (CLO)

Ms. Lo Bessette also serves as Secretary and CLO of other funds. Ms. Lo Bessette serves as CLO, Secretary, and Senior Vice President of Fidelity Management & Research Company LLC (investment adviser firm, 2019-present); and CLO of Fidelity Management & Research (Hong Kong) Limited, FMR Investment Management (UK) Limited, and Fidelity Management & Research (Japan) Limited (investment adviser firms, 2019-present). She is a Senior Vice President and Deputy General Counsel of FMR LLC (diversified financial services company, 2019-present), and is an employee of Fidelity Investments. Previously, Ms. Lo Bessette served as CLO, Secretary, and Senior Vice President of FMR Co., Inc. (investment adviser firm, 2019); Secretary of Fidelity SelectCo, LLC and Fidelity Investments Money Management, Inc. (investment adviser firms, 2019). Prior to joining Fidelity Investments, Ms. Lo Bessette was Executive Vice President, General Counsel (2016-2019) and Senior Vice President, Deputy General Counsel (2015-2016) of OppenheimerFunds (investment management company) and Deputy Chief Legal Officer (2013-2015) of Jennison Associates LLC (investment adviser firm).

Chris Maher (1972)

Year of Election or Appointment: 2017

Assistant Treasurer

Mr. Maher serves as Assistant Treasurer of other funds. Mr. Maher is Vice President of Valuation Oversight, serves as Assistant Treasurer of FMR Capital, Inc. (2017-present), and is an employee of Fidelity Investments. Previously, Mr. Maher served as Vice President of Asset Management Compliance (2013), Vice President of the Program Management Group of FMR (investment adviser firm, 2010-2013), and Vice President of Valuation Oversight (2008-2010).

Kenneth B. Robins (1969)

Year of Election or Appointment: 2018

Chief Compliance Officer

Mr. Robins also serves as an officer of other funds. Mr. Robins serves as Compliance Officer of Fidelity Management & Research Company LLC (investment adviser firm, 2016-present) and is an employee of Fidelity Investments (2004-present). Previously, Mr. Robins served as Compliance Officer of FMR Co., Inc. (investment adviser firm, 2016-2019), as Executive Vice President of Fidelity Investments Money Management, Inc. (investment adviser firm, 2013-2016) and served in other fund officer roles.

Stacie M. Smith (1974)

Year of Election or Appointment: 2018

President and Treasurer

Ms. Smith also serves as an officer of other funds. Ms. Smith serves as Assistant Treasurer of FMR Capital, Inc. (2017-present), is an employee of Fidelity Investments (2009-present), and has served in other fund officer roles. Prior to joining Fidelity Investments, Ms. Smith served as Senior Audit Manager of Ernst & Young LLP (accounting firm, 1996-2009). Previously, Ms. Smith served as Assistant Treasurer (2013-2019) and Deputy Treasurer (2013-2016) of certain Fidelity® funds.

Marc L. Spector (1972)

Year of Election or Appointment: 2017

Assistant Treasurer

Mr. Spector also serves as an officer of other funds. Mr. Spector serves as Assistant Treasurer of FMR Capital, Inc. (2017-present) and is an employee of Fidelity Investments (2016-present). Prior to joining Fidelity Investments, Mr. Spector served as Director at the Siegfried Group (accounting firm, 2013-2016), and prior to Siegfried Group as audit senior manager at Deloitte & Touche (accounting firm, 2005-2013).

Jim Wegmann (1979)

Year of Election or Appointment: 2019

Assistant Treasurer

Mr. Wegmann also serves as Assistant Treasurer of other funds. Mr. Wegmann is an employee of Fidelity Investments (2011-present).

Shareholder Expense Example

As a shareholder of the Fund, you incur two types of costs: (1) transaction costs and (2) ongoing costs, including management fees and other Fund expenses. This Example is intended to help you understand your ongoing costs (in dollars) of investing in the Fund and to compare these costs with the ongoing costs of investing in other mutual funds.

The Example is based on an investment of $1,000 invested at the beginning of the period and held for the entire period (June 1, 2019 to November 30, 2019).

Actual Expenses

The first line of the accompanying table provides information about actual account values and actual expenses. You may use the information in this line, together with the amount you invested, to estimate the expenses that you paid over the period. Simply divide your account value by $1,000.00 (for example, an $8,600 account value divided by $1,000.00 = 8.6), then multiply the result by the number in the first line under the heading entitled "Expenses Paid During Period" to estimate the expenses you paid on your account during this period. In addition, the Fund, as a shareholder in the underlying Fidelity Central Funds, will indirectly bear its pro-rata share of the fees and expenses incurred by the underlying Fidelity Central Funds. These fees and expenses are not included in the Fund's annualized expense ratio used to calculate the expense estimate in the table below.

Hypothetical Example for Comparison Purposes

The second line of the accompanying table provides information about hypothetical account values and hypothetical expenses based on the Fund's actual expense ratio and an assumed rate of return of 5% per year before expenses, which is not the Fund's actual return. The hypothetical account values and expenses may not be used to estimate the actual ending account balance or expenses you paid for the period. You may use this information to compare the ongoing costs of investing in the Fund and other funds. To do so, compare this 5% hypothetical example with the 5% hypothetical examples that appear in the shareholder reports of the other funds. In addition, the Fund, as a shareholder in the underlying Fidelity Central Funds, will indirectly bear its pro-rata share of the fees and expenses incurred by the underlying Fidelity Central Funds. These fees and expenses are not included in the Fund's annualized expense ratio used to calculate the expense estimate in the table below.

Please note that the expenses shown in the table are meant to highlight your ongoing costs only and do not reflect any transaction costs. Therefore, the second line of the table is useful in comparing ongoing costs only, and will not help you determine the relative total costs of owning different funds.

  Annualized Expense Ratio-A  Beginning
Account Value
June 1, 2019 
Ending
Account Value
November 30, 2019 
Expenses Paid
During Period-B
June 1, 2019
to November 30, 2019 
Actual  .21%  $1,000.00  $1,169.90  $1.14 
Hypothetical-C    $1,000.00  $1,024.02  $1.07 

 A Annualized expense ratio reflects expenses net of applicable fee waivers.

 B Expenses are equal to the Fund's annualized expense ratio, multiplied by the average account value over the period, multiplied by 183/365 (to reflect the one-half year period).

 C 5% return per year before expenses

Distributions (Unaudited)

The Board of Trustees of Fidelity Nasdaq Composite Index Tracking Stock voted to pay on December 26, 2019, to shareholders of record at the opening of business on December 20, 2019, a distribution of $3.142 per share derived from capital gains realized from sales of portfolio securities and a dividend of $.879 per share from net investment income.

The fund hereby designates as a capital gain dividend with respect to the taxable year ended November 30, 2019, $18,885,674, or, if subsequently determined to be different, the net capital gain of such year.

The fund designates 66%, 90%, 90%, and 90% of the dividends distributed in December, March, June, and September, respectively during the fiscal year as qualifying for the dividends–received deduction for corporate shareholders.

The fund designates 82%, 94%, 94%, and 94% of the dividends distributed in December, March, June, and September, respectively during the fiscal year as amounts which may be taken into account as a dividend for the purposes of the maximum rate under section 1(h)(11) of the Internal Revenue Code.

The fund will notify shareholders in January 2020 of amounts for use in preparing 2019 income tax returns.

Board Approval of Investment Advisory Contracts and Management Fees

Fidelity Nasdaq Composite Index Tracking Stock

At its November 2019 meeting, the Board of Trustees, including the Independent Trustees (together, the Board), voted to approve an amended and restated management contract and amended and restated sub-advisory agreements, including a sub-advisory agreement with Geode Capital Management, LLC (Geode) (together, the Amended and Restated Contracts) for the fund, effective January 1, 2020, for a one month period through January 31, 2020, in connection with an upcoming consolidation of certain of Fidelity's advisory businesses.

The Board considered that, on or about January 1, 2020, each of FMR Co., Inc. (FMRC), Fidelity Investments Money Management, Inc. (FIMM), and SelectCo, LLC (SelectCo) will merge with and into Fidelity Management & Research Company (FMR) and that, after the merger, FMR will redomicile as a Delaware limited liability company. The Board also approved the termination of the sub-advisory agreement with FMRC upon the completion of the merger. The Board noted that the Amended and Restated Contracts would be updated to reflect the renamed adviser, Fidelity Management & Research Company LLC and its new form of organization and domicile. The Board also noted that the Amended and Restated Contracts will not change the investment processes, the level or nature of services provided, the resources and personnel allocated, trading and compliance operations, or any fees or expenses paid by the fund.

The Board concluded that the fund's Amended and Restated Contracts are fair and reasonable, and that the fund's Advisory Contracts should be approved through January 31, 2020.

In connection with its consideration of future renewals of the fund's Amended and Restated Contracts, the Board will consider: (i) the nature, extent and quality of services provided to the fund, including shareholder and administrative services and investment performance; (ii) the competitiveness of the management fee and total expenses for the fund; (iii) the costs of the services and profitability, including the revenues earned and the expenses incurred in conducting the business of developing, marketing, distributing, managing, administering, and servicing the fund and its shareholders, to the extent applicable; and (iv) whether there have been economies of scale in respect of the Fidelity funds, whether the Fidelity funds (including the fund) have appropriately benefited from any such economies of scale, and whether there is the potential for realization of any further economies.

Based on its evaluation of all of the conclusions noted above, and after considering all factors it believed relevant, the Board ultimately concluded that the fund's management fee structure is fair and reasonable, and that the continuation of the fund's Amended and Restated Contracts should be approved.

Board Approval of Investment Advisory Contracts and Management Fees

Fidelity Nasdaq Composite Index Tracking Stock

At its November 2019 meeting, the Board of Trustees, including the Independent Trustees (together, the Board), voted to approve an amended and restated management contract with FMR Co., Inc. (FMRC) for the fund (the Amended Management Contract) and the sub-advisory agreement with Geode Capital Management, LLC (Geode) (together with the Amended Management Contract, the Amended and Restated Contracts): (1) to implement an all-inclusive fee structure and lower the management fee rate from 0.24% to 0.21% effective December 1, 2019; and (2) to reflect the upcoming consolidation of certain of Fidelity’s advisory businesses effective on or about January 1, 2020.

The Board considered that, on or about January 1, 2020, FMRC will merge with and into Fidelity Management & Research Company (FMR) and that, after the merger, FMR will redomicile as a Delaware limited liability company. The Board noted that the Amended and Restated Contracts would be updated to reflect the renamed adviser, Fidelity Management & Research Company LLC and its new form of organization and domicile. The Board also noted the Amended and Restated Contracts will not change the investment processes, the level or nature of services provided, the resources and personnel allocated, trading and compliance operations, or any fees or expenses paid by the fund.

The Board, assisted by the advice of fund counsel and Independent Trustees' counsel, considered a broad range of information.

Nature, Extent, and Quality of Services Provided.  The Board noted that it previously received and considered materials relating to the nature, extent and quality of services provided by FMR and the fund’s sub-adviser, Geode to the fund, including the resources dedicated to investment management and support services, shareholder and administrative services, the benefits to shareholders of investment in a large fund family, and the investment performance of the fund in connection with the annual renewal of the fund's current management contract and sub-advisory agreement (Advisory Contracts). At its January 2019 meeting, the Board concluded that the nature, extent and quality of the services provided to the fund under the existing Advisory Contracts should benefit the fund's shareholders. The Board noted that approval of the Amended and Restated Contracts would not change the fund's portfolio manager, the investment processes, the level or nature of services provided, the resources and personnel allocated or trading and compliance operations. The Board concluded that the nature, extent, and quality of services to be provided to the fund under the Amended and Restated Contracts will continue to benefit the fund's shareholders.

Competitiveness of Management Fee and Total Expense Ratio.  The Board considered that it received and reviewed information regarding the fund's current management fee and total expense ratio compared to "mapped groups" of competitive funds and classes in connection with the annual renewal of the Advisory Contracts.

Based on its review, the Board concluded at its January 2019 meeting that the fund's current management fee and total expenses are fair and reasonable in light of the services that the fund receives and the other factors considered.

The Board considered that the Amended Management Contract would implement an all-inclusive fee set below the fund's current management fee level and payable to FMR for managing the fund and paying all of the fund's operating expenses, subject to certain exceptions. The Board considered that the Amended Management Contract would result in a decrease to the fund's management fee rate by 3.0 basis points, and that the management fee rate would continue to rank below the total mapped group median of its competitor funds based on the competitive mapped group data provided to the Board in connection with the annual renewal of the existing management contract.

Based on its review, the Board concluded that the management fee and the total expenses continue to be fair and reasonable in light of the services that the fund receives and the other factors considered.

Costs of the Services and Profitability.  The Board considered that it previously reviewed information regarding the revenues earned and the expenses incurred by FMR in providing services to the fund and the level of FMR's profitability. At its January 2019 meeting, the Board concluded that it was satisfied that FMR's profitability in connection with the operation of the fund was not excessive under the circumstances. Because the Board was approving an arrangement that would reduce the management fee rate, the Board did not consider the costs of the services provided by and the profits realized by FMR to be significant factors in its decision to approve the Amended Management Contract.

Economies of Scale.  The Board considered that it previously received and reviewed information regarding whether there have been economies of scale in respect of the management of the Fidelity funds, whether the Fidelity funds (including the fund) have appropriately benefited from any such economies of scale, and whether there is potential for realization of any further economies of scale and that it concluded, at its January 2019 meeting, that economies of scale, if any, are being appropriately shared between fund shareholders and Fidelity. The Board did not consider economies of scale to be a significant factor in its decision to approve the Amended Management Contract because the all-inclusive fee will be set below the fund's current management fee.

Based on its evaluation of all of the conclusions noted above, and after considering all factors it believed relevant, the Board ultimately concluded that the fund's advisory fee structures are fair and reasonable, and that the Amended and Restated Contracts should be approved.





FIDELITY INVESTMENTS

ETF-ANN-0120
1.795540.116


Item 2.

Code of Ethics


As of the end of the period, November 30, 2019, Fidelity Commonwealth Trust (the trust) has adopted a code of ethics, as defined in Item 2 of Form N-CSR, that applies to its President and Treasurer and its Chief Financial Officer.  A copy of the code of ethics is filed as an exhibit to this Form N-CSR.


Item 3.

Audit Committee Financial Expert


The Board of Trustees of the trust has determined that Joseph Mauriello is an audit committee financial expert, as defined in Item 3 of Form N-CSR.  Mr. Mauriello is independent for purposes of Item 3 of Form N-CSR.  



Item 4.  

Principal Accountant Fees and Services


Fees and Services


The following table presents fees billed by PricewaterhouseCoopers LLP (PwC) in each of the last two fiscal years for services rendered to Fidelity Nasdaq Composite Index Tracking Stock (the Fund):


Services Billed by PwC


November 30, 2019 FeesA


Audit Fees

Audit-Related Fees

Tax Fees

All Other Fees

Fidelity Nasdaq Composite Index Tracking Stock

 $54,000

$4,400

 $5,900

 $2,000



November 30, 2018 FeesA


Audit Fees

Audit-Related Fees

Tax Fees

All Other Fees

Fidelity Nasdaq Composite Index Tracking Stock

 $52,000

$4,600

 $5,400

 $2,200



A Amounts may reflect rounding.


The following table(s) present(s) fees billed by PwC that were required to be approved by the Audit Committee for services that relate directly to the operations and financial reporting of the Fund(s) and that are rendered on behalf of Fidelity Management & Research Company ("FMR") and entities controlling, controlled by, or under common



control with FMR (not including any sub-adviser whose role is primarily portfolio management and is subcontracted with or overseen by another investment adviser) that provide ongoing services to the Fund(s) (Fund Service Providers):


Services Billed by PwC




November 30, 2019A

November 30, 2018A

Audit-Related Fees

 $7,890,000

 $7,745,000

Tax Fees

$10,000

$20,000

All Other Fees

$-

$-


A Amounts may reflect rounding.


Audit-Related Fees represent fees billed for assurance and related services that are reasonably related to the performance of the fund audit or the review of the fund's financial statements and that are not reported under Audit Fees.


Tax Fees represent fees billed for tax compliance, tax advice or tax planning that relate directly to the operations and financial reporting of the fund.


All Other Fees represent fees billed for services provided to the fund or Fund Service Provider, a significant portion of which are assurance related, that relate directly to the operations and financial reporting of the fund, excluding those services that are reported under Audit Fees, Audit-Related Fees or Tax Fees.  


Assurance services must be performed by an independent public accountant.


* * *


The aggregate non-audit fees billed by PwC for services rendered to the Fund(s), FMR (not including any sub-adviser whose role is primarily portfolio management and is subcontracted with or overseen by another investment adviser), and any Fund Service Provider for each of the last two fiscal years of the Fund(s) are as follows:


Billed By

November 30, 2019A

November 30, 2018A

PwC

$12,550,000

$10,950,000



A Amounts may reflect rounding.


The trust's Audit Committee has considered non-audit services that were not pre-approved that were provided by PwC to Fund Service Providers to be compatible with maintaining the independence of PwC in its(their) audit of the Fund(s), taking into account representations from PwC, in accordance with Public Company Accounting Oversight Board rules, regarding its independence from the Fund(s) and its(their) related



entities and FMRs review of the appropriateness and permissibility under applicable law of such non-audit services prior to their provision to the Fund(s) Service Providers.


Audit Committee Pre-Approval Policies and Procedures

 

The trusts Audit Committee must pre-approve all audit and non-audit services provided by a funds independent registered public accounting firm relating to the operations or financial reporting of the fund. Prior to the commencement of any audit or non-audit services to a fund, the Audit Committee reviews the services to determine whether they are appropriate and permissible under applicable law.


The Audit Committee has adopted policies and procedures to, among other purposes, provide a framework for the Committees consideration of non-audit services by the audit firms that audit the Fidelity funds. The policies and procedures require that any non-audit service provided by a fund audit firm to a Fidelity fund and any non-audit service provided by a fund auditor to a Fund Service Provider that relates directly to the operations and financial reporting of a Fidelity fund (Covered Service) are subject to approval by the Audit Committee before such service is provided.


All Covered Services must be approved in advance of provision of the service either: (i) by formal resolution of the Audit Committee, or (ii) by oral or written approval of the service by the Chair of the Audit Committee (or if the Chair is unavailable, such other member of the Audit Committee as may be designated by the Chair to act in the Chairs absence). The approval contemplated by (ii) above is permitted where the Treasurer determines that action on such an engagement is necessary before the next meeting of the Audit Committee.


Non-audit services provided by a fund audit firm to a Fund Service Provider that do not relate directly to the operations and financial reporting of a Fidelity fund are reported to the Audit Committee periodically.


Non-Audit Services Approved Pursuant to Rule 2-01(c)(7)(i)(C) and (ii) of Regulation S-X (De Minimis Exception)


There were no non-audit services approved or required to be approved by the Audit Committee pursuant to the De Minimis Exception during the Funds(s) last two fiscal years relating to services provided to (i) the Fund(s) or (ii) any Fund Service Provider that relate directly to the operations and financial reporting of the Fund(s).


Item 5.

Audit Committee of Listed Registrants


The Audit Committee is a separately-designated standing audit committee in accordance with Section 3(a)(58)(A) of the Securities Exchange Act of 1934.  As of November 30, 2019, the members of the Audit Committee were Joseph Mauriello, Donald F. Donahue, Alan J. Lacy and Michael E. Wiley. 




Item 6.  

Investments


(a)

Not applicable.


(b)

Not applicable.


Item 7.

Disclosure of Proxy Voting Policies and Procedures for Closed-End Management Investment Companies


Not applicable.


Item 8.

Portfolio Managers of Closed-End Management Investment Companies


Not applicable.


Item 9.  

Purchase of Equity Securities by Closed-End Management Investment Company and Affiliated Purchasers


Not applicable.


Item 10.

Submission of Matters to a Vote of Security Holders


There were no material changes to the procedures by which shareholders may recommend nominees to the trusts Board of Trustees.


Item 11.

Controls and Procedures


(a)(i)  The President and Treasurer and the Chief Financial Officer have concluded that the trusts disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act) provide reasonable assurances that material information relating to the trust is made known to them by the appropriate persons, based on their evaluation of these controls and procedures as of a date within 90 days of the filing date of this report.


(a)(ii)  There was no change in the trusts internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act) that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the trusts internal control over financial reporting.


Item 12.

Disclosure of Securities Lending Activities for Closed-End Management

Investment Companies


Not applicable.


Item 13.

Exhibits


(a)

(1)

Code of Ethics pursuant to Item 2 of Form N-CSR is filed and attached hereto as EX-99.CODE ETH.

(a)

(2)

Certification pursuant to Rule 30a-2(a) under the Investment Company Act of 1940 (17 CFR 270.30a-2(a)) is filed and attached hereto as Exhibit 99.CERT.

(a)

(3)

Not applicable.

(b)


Certification pursuant to Rule 30a-2(b) under the Investment Company Act of 1940 (17 CFR 270.30a-2(b)) is furnished and attached hereto as Exhibit 99.906CERT.




SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


Fidelity Commonwealth Trust



By:

/s/Stacie M. Smith


Stacie M. Smith


President and Treasurer



Date:

January 24, 2020


Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.



By:

/s/Stacie M. Smith


Stacie M. Smith


President and Treasurer



Date:

January 24, 2020



By:

/s/John J. Burke III


John J. Burke III


Chief Financial Officer



Date:

January 24, 2020

 





Grafico Azioni Fidelity Nasdaq Composit... (NASDAQ:ONEQ)
Storico
Da Giu 2024 a Lug 2024 Clicca qui per i Grafici di Fidelity Nasdaq Composit...
Grafico Azioni Fidelity Nasdaq Composit... (NASDAQ:ONEQ)
Storico
Da Lug 2023 a Lug 2024 Clicca qui per i Grafici di Fidelity Nasdaq Composit...